WO2000042422A1 - Disposable test strips with integrated reagent/blood separation layer - Google Patents

Disposable test strips with integrated reagent/blood separation layer Download PDF

Info

Publication number
WO2000042422A1
WO2000042422A1 PCT/US2000/000620 US0000620W WO0042422A1 WO 2000042422 A1 WO2000042422 A1 WO 2000042422A1 US 0000620 W US0000620 W US 0000620W WO 0042422 A1 WO0042422 A1 WO 0042422A1
Authority
WO
WIPO (PCT)
Prior art keywords
conductive
test strip
conductive element
blood
separation layer
Prior art date
Application number
PCT/US2000/000620
Other languages
French (fr)
Inventor
Jerome F. Mcaleer
David Scott
Geoff Hall
Manuel Alvarez-Icaza
Elliott V. Plotkin
Oliver W. H. Davies
Original Assignee
Inverness Medical Technology, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22858812&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2000042422(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Inverness Medical Technology, Inc. filed Critical Inverness Medical Technology, Inc.
Priority to US09/869,887 priority Critical patent/US7112265B1/en
Priority to EP00906895A priority patent/EP1155310B1/en
Priority to CA002358464A priority patent/CA2358464C/en
Priority to DE60025334T priority patent/DE60025334T2/en
Priority to BRPI0008615-0A priority patent/BR0008615B1/en
Priority to AU28479/00A priority patent/AU763723B2/en
Priority to JP2000593945A priority patent/JP3699898B2/en
Publication of WO2000042422A1 publication Critical patent/WO2000042422A1/en
Priority to HK02105542.0A priority patent/HK1043832B/en
Priority to US11/453,174 priority patent/US7807031B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/002Electrode membranes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/004Enzyme electrodes mediator-assisted
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/005Enzyme electrodes involving specific analytes or enzymes
    • C12Q1/006Enzyme electrodes involving specific analytes or enzymes for glucose
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3272Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5002Partitioning blood components

Definitions

  • This application relates to disposable test strips for use in electrochemical determinations of blood analytes such as glucose, and to methods and compositions for use in making such strips.
  • Glucose monitoring is a fact of everyday life for diabetic individuals, and the accuracy of such monitoring can literally mean the difference between life and death.
  • a number of glucose meters are now available which permit the individual to test the glucose level in a small amount of blood. Many of these meters detect glucose in a blood sample electrochemically, by detecting the oxidation of blood glucose using an enzyme such as glucose oxidase provided as part of a disposable, single-use electrode system. Examples of devices of this type are disclosed in European Patent No. 0 127 958, and US Patents Nos. 5,141,868, 5,286,362, 5,288,636, and 5,437,999 which are incorporated herein by reference for purposes of those countries which permit such incorporation.
  • existing glucose test strips for use in electrochemical meters comprise a substrate, working and reference electrodes formed on the surface of the substrate, and a means for making connection between the electrodes and the meter.
  • the working electrode is coated with an enzyme capable of oxidizing glucose, and a mediator compound which transfers electrons from the enzyme to the electrode resulting in a measurable current when glucose is present.
  • mediator compounds include ferricyanide, metallocene compounds such as ferrocene, quinones, phenazinium salts, redox indicator DCPIP, and imidazole-substituted osmium compounds.
  • Working electrodes of this type have been formulated in a number of ways.
  • mixtures of conductive carbon, glucose oxidase and a mediator have been formulated into a paste or ink and applied to a substrate.
  • this application is done by screen printing in order to obtain the thin layers suitable for a small flat test strip.
  • screen printing introduces problems to the operation of the electrode.
  • screen printed electrodes formed from carbon pastes or inks are prone to break up on contact with the sample. The consequences of this breakup are two-fold. Firstly, the components of the electrode formulation are released into solution.
  • the present invention provides an improved disposable test strip for use in a test meter of the type which receives a disposable test strip and a sample of blood from a patient and performs an electrochemical analysis of the amount of a blood analyte such as glucose in the sample.
  • the test strip comprises: (a) a substrate;
  • the integrated reagent/blood separation layer comprises reagents for the electrochemical detection of the analyte dispersed in a non-conductive matrix effective to exclude blood cells from the surface of the first conductive element while permitting access to the first conductive element by soluble electroactive species.
  • a glucose test strip is formed with an integrated reagent/blood separation layer comprising a filler which has both hydrophobic and hydrophilic surface regions, an enzyme effective to oxidize glucose, e.g., glucose oxidase, and a mediator effective to transfer electrons from the enzyme to the conductive element.
  • the filler is selected to have a balance of hydrophobicity and hydrophilicity such that on drying the integrated reagent/blood separation layer forms a two-dimensional network on the surface of the conductive element.
  • Preferred integrated reagent/blood separation layers comprise non- conductive silica fillers in combination with materials such as hydroxyethyl cellulose (HEC).
  • HEC hydroxyethyl cellulose
  • the test strips are prepared with an insulation layer disposed over at least the first conductive element.
  • This insulation layer has an aperture formed in it which is aligned with a portion of the first conductive element, and the integrated reagent/blood separation layer is disposed to make contact with the first conductive element through this aperture.
  • Figs. 1A and IB show an electrode structure useful in a disposable test strip in accordance with the invention
  • Fig. 2 shows a test strip in accordance with the invention
  • Figs. 3 A - 3C show the current measured as a function of glucose concentration for three different hematocrit levels
  • Fig. 4 shows the relationship of the glucose-concentration dependence of the measured current as a function of hematocrit
  • Figs. 5A - 5C show the current measured as a function of glucose in blood and a control solution for three different conductive elements
  • Figs. 6A and 6B show the current measured as a function of glucose at two different temperatures
  • Fig. 7 shows a further embodiment of a glucose test strip according to the invention
  • Figs 8 A and 8B show current transients observed using a test strip according to the invention and a commercial carbon-based test strip;
  • Figs. 9A-C show a three-step process for manufacture of test strips in accordance with the invention.
  • Figs. 10A-10G show the manufacture of a test strip in accordance with the invention.
  • Figs. 1 A and IB show electrodes useful in a disposable test strip in accordance with the invention. As shown, the electrodes are formed on a substrate 10. On the substrate 10 are placed two conductive elements 14' and 16, connected by leads 14 and 15 to conductive contacts 11, 12, and 13. An insulating mask 18 is then formed, leaving at least a portion of conductive elements 14' and 16, and the contacts 11, 12 and 13 exposed. A non-conductive integrated reagent/blood separation layer 17 is then applied over the insulating mask 18 to make contact with conductive element 16.
  • Fig. 1 The assembly shown in Fig. 1 provides a fully functional assembly for the measurement of a blood analyte when connected to a meter.
  • the electrode strips of the invention are finished by applying a nylon or polyester mesh 21 over the sample application region defined by the location of the integrated reagent/blood separation layer 17 of the electrode assembly 22, and then a top cover 23 to prevent splashing of the blood sample.
  • Fig. 2 The polyester mesh acts to guide the sample to the reference electrode, conductive element 14', thereby triggering the device and initiating the test.
  • a non-conductive integrated reagent/blood separation layer provides an important distinction from and advantage over known test strips which utilize a conductive reagent-containing slurry to print the reagents.
  • the printed slurry becomes a functional part of the electrode and charge transfer can take place at the outer surface of the reagent layer. If the layer is in direct contact with blood, i.e., when no intervening separation layer has been deposited, red and white blood cells, fat and proteins present in the sample can interact with the reagent layer and interfere with the measurement of the amount of analyte in the sample.
  • the integrated reagent/blood separation layer is non-conductive, and thus is not a part of the electrode either structurally or functionally. Charge transfer does not occur unless electroactive species pass through the openings/pores of the integrated reagent/blood separation layer to reach the underlying conductive element.
  • the integrated reagent/blood separation layer provides a barrier to the passage of interferents such as cells and macromolecules to the conductive element resulting in a device with superior properties that is simpler to make.
  • the integrated reagent/blood separation layer be deposited in such a way that no portion of the conductive element 16 be directly exposed to the sample when it is placed in the sample application region.
  • the methodology described above, in which an insulating layer with apertures providing access to the conductive elements 14' and 16 is utilized is particularly suited for achieving this result.
  • this methodology allows the formation of the test strip in only three steps. In the first step (Fig. 9 A), two conductive elements 14' and 16 and associated leads and contacts are deposited on a substrate. In a second step (Fig. 9B), a layer of insulating material is deposited over the conductive elements.
  • the insulating material has two apertures 94 and 96, one in alignment with each of the conductive elements 14' and 16.
  • the integrated reagent/blood separation layer 17 is deposited over the aperture 96. By making the deposited layer 17 larger in dimensions than the aperture 96, the reagent layer completely covers the underlying conductive element such that it is not exposed directly to the sample, thereby providing effective blood separation.
  • the complete coverage of conductive element 16 also addresses another source of error which can occur as a result of electrochemical oxidation or small molecules such as ascorbic acid, uric acid and acetaminophen which may be present in the sample.
  • electrochemical oxidation or small molecules such as ascorbic acid, uric acid and acetaminophen which may be present in the sample.
  • the oxidation of these molecules at the surface of the electrode leads to spuriously elevated current levels, and thus an inaccurate measurement of the desired analyte, e.g. glucose.
  • the integrated reagent/blood separation layer of invention will not generally exclude these molecules, since they are small compared to the pore sizes observed.
  • a pH buffer in the integrated reagent/blood separation layer one can shift the local pH at the electrode surface to a level where electrochemical potential of these species is higher.
  • the use of an integrated reagent/blood separation layer in which the pH is buffered to a level of around pH 5 will substantially reduce the impact of these interferents.
  • the entire conductive element must be covered, since even a relatively small region of exposed (not buffered) electrode surface can result in a large interference current.
  • test strips of the invention provide performance benefits resulting from the separation of the conductive element from the blood sample
  • the test strips of the invention are also resistant to other sources of error.
  • reagents may diffuse laterally away from the original deposit. If the reagent layer is deposited directly on the conductive element, these reagents will continue to contribute to the measured signal. Any variations in convective diffusion from test to test (for example as a result of differences in temperature or differences in the handling of the instrument) will therefore be manifested as irreproducibility in the signal. If the reagent layer overlaps the insulation print, however, lateral diffusion away from the aperture will not contribute to the signal and therefore will not give rise to variations in the signal.
  • the methodology outlined in Figs. 9A-C offers several advantages from a manufacturing perspective.
  • the "active area" is defined by the area of the reagent layer. The precision of the test is therefore determined by the precision with which the reagent layer can be printed.
  • the active area is defined by the size of the aperture in the insulation layer. Since insulation layers are typically printed using a finer screen, much better edge definition, and thus greater device precision can be achieved. Thus, neither the area of conductive element 16 nor of the integrated reagent/blood separation layer are critical to the performance characteristics of the finished test strip. The conductive elements and the integrated reagent/blood separation layer may therefore be applied using techniques which provide less precision than can be employed in other processes.
  • the important function of the insulation mask is to provide an aperture defining the contact region between conductive element 16 and the integrated reagent/blood separation layer 17.
  • the second conductive element can be exposed along an edge of the insulation layer, or may be located on a facing surface in a folded electrode structure.
  • the substrate 10 used in making the test strips of the invention can be any non-conducting, dimensionally stable material suitable for insertion into a glucose test meter.
  • Suitable materials include polyester films, for example a 330 micron polyester film, and other insulating substrate materials such as polyvinyl chloride (PVC) and polycarbonate.
  • the conductive elements and associated leads and contacts can be formed from essentially any conductive material including silver, Ag/AgCl, gold, or platinum/carbon, and need not all be formed from the same material.
  • the conductive element 16 is preferably formed from conductive carbon. Preferred conductive carbon are ERCON ERC1, ERCON ERC2 and Acheson Carbon Electrodag 423. Carbon with these specifications is available from Ercon Inc. (Waltham, Massachusetts, USA), or Acheson Colloids, (Princes Rock, Madison, England).
  • the conductive element 16 makes contact with working electrode track 15, and is close to, but not contacting conductive element 14' disposed as the end of reference electrode track 14.
  • the insulating layer 18 can be formed from polyester-based printable dielectric materials such as ERCON R488-B(HV)-B2 Blue.
  • the top cover 23 is suitably formed from a polyester strip or a "hot melt” coated plastic.
  • test strips of the present invention do not require the formation of a discrete exit port to permit air to escape from the device as sample enters the electrode chamber but instead uses a distributed exit along all of the edges of the mesh. As the sample fluid wicks along the mesh, air seeps out of the edges of the mesh all around the device underneath the top layer. The sample fluid does not seep out because the insulation layer imparts significant hydrophobicity to that part of the mesh. The liquid sample therefore remains in the central hydrophilic region.
  • This layer can be formed from a mixture containing a filler which has both hydrophobic and hydrophilic surface regions, and in the case of a glucose test strip, an enzyme which can oxidize glucose, and a mediator which can transfer electrons from the enzyme to the underlying conductive element layer 16.
  • This layer is suitably formed by formulating an ink which contains the filler, the enzyme and the mediator in a suitable carrier and using this ink to print the layer 17 onto the device.
  • a preferred filler for use in the layer 17 is silica. Silica is available in a variety of grades and with a variety of surface modifications.
  • silica having a surface modification to render it partially hydrophobic is used.
  • Materials of this type include Cab-O-Sil TS610, a silica which is modified by partial surface treatment with methyl dichlorosilane; Cab-o-Sil 530, a silica which is modified by full surface treatment with hexamethyl disilazane; Spherisorb C4 silica, which is surface modified with 4 carbon chains; and other similarly modified silicas, or combinations thereof.
  • Silica with a surface modification which is too hydrophobic should be avoided. For example, it has been observed that C18-modified silica is too hydrophobic to form a printable ink.
  • the particles are broken down by homogenization to expose hydrophilic inner portions of the silica particles.
  • the actual particles present in the ink therefore have both hydrophilic and hydrophobic regions.
  • the hydrophilic regions form hydrogen bonds with each other and with water.
  • this material When this material is formulated into an ink as described below in Example 1, and screen printed onto the conductive element 16, the dual nature of the material causes it two form layers of two-dimensional networks which take form as a kind of honeycomb which is visible upon microscopic examination . On rehydration, this layer does not break up, but swells to form a gelled reaction zone in the vicinity of the underlying conductive element 16. Reactants such as enzyme, mediator and glucose move freely within this zone, but interfering species such as red blood cells containing oxygenated hemoglobin are excluded.
  • the integrated reagent/blood separation layer is advantageously formed from an aqueous composition containing 2 to 10 % by weight, preferably 4 to 10 % and more preferably about 4.5 % of a binder such as hydroxyethylcellulose or mixtures of hydroxyethylcellulose with alginate or other thickeners; 3 to 10 % by weight, preferably 3 to 5 % and more preferably about
  • a binder such as hydroxyethylcellulose or mixtures of hydroxyethylcellulose with alginate or other thickeners
  • silica 8 to 20 % by weight, preferably 14 to 18 % and more preferably about 16 % of a mediator such as ferricyanide; and .4 to 2 % by weight, preferably 1 to 2 % and more preferably about 1.6 % of an enzyme such as glucose oxidase, assuming a specific activity of about 250 units/mg, or about 1000 to 5000 units per gram of ink formulation.
  • a mediator such as ferricyanide
  • an enzyme such as glucose oxidase
  • the integrated reagent/blood separation layer may also include additional ingredients without departing from the scope of the invention.
  • the nonconducting layer may include an antifoam.
  • the nonconducting layer may be formulated with a buffering agent to control the pH of the reaction zone.
  • the pH may be maintained at a level within the range from about pH 3 to pH 10.
  • it is of particular utility to maintain the pH of the device at a level above 8 because at this pH oxygen bound to hemoglobin is not released.
  • the reaction rate of glucose oxidase with oxygen is very low.
  • selection of an appropriate pH can further stabilize the performance of the test strip against the effects of varying hematocrit.
  • maintaining a low pH (below pH 5.5, the optimium pH for reaction of glucose oxidase with oxygen) may be preferred.
  • maintaning a pH of around pH 5 is better if the primary concern is the elimination of electrochemical interferences arising from oxidation of interfering substances such as ascorbic acid, uric acid or acetaminophen, since these compounds are more difficult to oxidize at lower pH.
  • a preferred embodiment of the invention is a glucose test strip as described above, the test strips of the invention are not limited to the detection of glucose.
  • a fructosamine test strip could include two layers disposed over the conductive element.
  • the first, lower layer is formed from an ink comprising a carbonate buffer (pH>10) in a silica mix substantially as described in Example 7 but without enzyme, mediator or citrate buffer.
  • the second, upper layer is formed form an ink further comprising an oxidant such a ferricyanide.
  • Fig. 7 shows an alternative embodiment of the invention.
  • a second non-conductive layer 71 is disposed over the integrated reagent/blood separation layer 17.
  • This layer is formed from a composition which is identical to the first integrated reagent/blood separation layer except that the enzyme or both the enzyme and the mediator are omitted.
  • This layer further isolates the conductive element 16 from contact with oxygen-carrying red blood cells, thus reducing the effects of oxygen.
  • enzyme may tend to diffuse away from the surface of the electrode during the course of the measurement, such a layer containing mediator can provide an increased region in which it will have mediator available for the transfer of electrons.
  • EXAMPLE 1 A non-conducting formulation for preparation of the integrated reagent/blood separation layer 17 was made as follows. 100 ml of 20 mM aqueous trisodium citrate was adjusted to pH 6 by the addition of 0.1 M citric acid. To this 6 g of hydroxyethyl cellulose (HEC) was added and mixed by homogenization. The mixture was allowed to stand overnight to allow air bubbles to disperse and then used as a stock solution for the formulation of the coating composition.
  • HEC hydroxyethyl cellulose
  • EXAMPLE 2 To prepare glucose test strips using the ink formulation of Example 1, a series of patterns are used to screen print layers onto a 330 micron polyester substrate (Melinex 329). The first step is the printing of carbon pads. An array of 10 X 50 pads of carbon is formed on the surface of the polyester substrate by printing with EC2 carbon. (Ercon) The printed substrate is then passed through a heated dryer, and optionally cured at elevated temperature (e.g. 70 °C) for a period of 1 to 3 weeks.
  • elevated temperature e.g. 70 °C
  • an array of silver/silver chloride connecting tracks and contacts is printed onto the substrate using ERCON R-414 (DPM-68)1.25 bioelectrode sensor coating material and dried.
  • One working track which makes contact with the carbon pad and one reference track is printed for each carbon pad in the array.
  • a dielectric layer is then printed using ERCON R488-B(HV)-B2 Blue and dried. The dielectric layer is printed in a pattern which covers substantially all of each device, leaving only the contacts, the tip of the reference electrode and the carbon pads uncovered.
  • Example 1 On top of the dielectric layer the ink of Example 1 is used to form a integrated reagent/blood separation layer overlaid on top of each conductive carbon pad.
  • Polyester mesh strips (Scrynel PET230 HC) are then laid down across the substrate in lines, covering the reactions areas exposed by the windows in the dielectric.
  • An 5 mm wide polyester strip (50 microns thick) is then applied over the top of the mesh strips, and the edges of the electrodes are heat sealed.
  • the substrate is cut up to provide 50 individual electrodes, for example having a size of 5.5 mm wide and 30 mm long.
  • EXAMPLE 3 Test strips manufactured using the ink formulation of Example 1 in the manner described in Example 2 were placed in a test meter with an applied voltage of 500 mV and used to test blood samples having varying glucose concentrations and hematocrits ranging from 40% to 60%.
  • Figs. 3A-3C show the current measured 25 seconds after applying the voltage as a function of the glucose concentration
  • Fig. 4 plots the slope of the glucose response as a function of hematocrit. As can be seen, the indicators produce highly reproducible current levels which are essentially independent of hematocrit.
  • EXAMPLE 4 Glucose test strips in accordance with the invention were made in accordance with Example 2, except the non-conductive layer was formed with 7 g
  • a Ercon EC 1 B Ercon EC2 C Ercon EC2 on top of Acheson Carbon, Electrodag 423 SS.
  • These test strips were used to measure varying levels of glucose in either a control solution (One Touch Control Solution, Lifescan Inc.) containing glucose in an inert solution or in blood at an applied voltage of 425 mV. The current observed 25 seconds after the voltage was applied was measured.
  • Figs. 5A - 5C show the results obtained for the three formulations, A, B, and C, respectively. In all cases, the slope of the line showing the response of the meter to different glucose concentrations was essentially the same whether the measurements were made in blood or the control solution.
  • Test strips prepared in accordance with Example 2 were tested at two different sample temperatures, namely 37 °C and 20 °C using an applied voltage of 425 mV.
  • Figs. 6A and 6B show the current measured 25 seconds after applying the voltage as a function of glucose concentration.
  • the slopes of the two lines are essentially identical (0.1068 at 20 °C versus 0.1009 at 37 °C), thus demonstrating that the test strips provide essentially temperature-independent behavior over a temperature range from ambient to physiological temperatures.
  • test strip of the invention provides a very flat transient which maintains more than 50% of the peak current for a period of more than 25 seconds after the initial response from the test strip.
  • the carbon-based electrode exhibited an almost immediate decay in the current, having lost 50% of the peak current in a period of the first 1 to 2 seconds after the initial response from the test strip. This makes timing of the measurement difficult if peak current values are to be captured, or reduces the dynamic range of the meter if current must be measured after substantial decay has occurred.
  • the test strips of the invention are advantageous in that the current generated in response to a given amount of glucose decays by less than 50% in the 5 seconds following peak current generation.
  • Figs. 10A-I shows the stepwise preparation of a test strip in accordance with the invention. As is apparent from a comparison of this test strip and the strip of Fig. 1, the precise arrangement of the electrodes on the strip is not critical. Further, different materials may be used in fabricating the strip.
  • the first step in fabricating the test strip is the deposition of silver tracks 101, 102 of substrate 100.
  • a preferred substrate is a 500 micron thick polyester film sold under the tradename ValoxTM.
  • the silver electrodes can be formed by screen printing using an ink composition formulated as in Example 2.
  • a second electrode print is carried out to form carbon conductive elements 103, 104 and 105 as shown in Fig 10B.
  • Conductive element 103 is formed in contact with silver track 101 and will form the working electrode in the finished test strip.
  • Carbon pads 104 and 105 connect electrically to the ends of silver tracks 101 and 102 and provide connection between the strip and a test meter.
  • the carbon conductive elements can be formed by screen printing with a conductive carbon ink formulation such as those described in the previous examples.
  • the next step in the manufacturing process is the deposition of an insulation layer 106 for example by screen printing an insulation ink, for example the dielectric ink of Example 2.
  • the insulation layer contains three windows 107, 108 and 109.
  • Window 108 is aligned with the end of the carbon conductive element 103.
  • Window 107 is aligned with the end of silver track 102 to provide access to the reference electrode.
  • the third window, 109 is provided to permit passage of insulation material from the second insulation coating through the mesh layer, but is not required.
  • Fig 10D shows the next step in the process, which is the formation of an integrated reagent/blood separation layer 110.
  • This layer is deposited over window 108 and extends over the insulation layer 106 along all sides of the window 108.
  • a suitable formulation for printing layer 110 has the following composition to provide an integrated reagent/blood separation layer with a buffered pH of about 6:
  • a layer of mesh 111 is deposit over the sample collection region of the test strip.
  • the mesh 111 is preferably a nylon mesh which has been pretreated with acetone and Fluorad FC 170C surfactant to render the mesh hydrophilic.
  • the purpose of the mesh 111 is the transport of the liquid sample evenly through the area between the working and reference electrodes.
  • a second insulation print 112 is then carried out using a sllightly more flexible insulation ink (ERCON Insulayer 820202) to define the sample collection region.
  • a tape cover 113 is then applied over the top of the test strip as described above in Example 2 to form a finished test strip. (Fig. 10G).

Abstract

An improved disposable glucose test strip for use in a test meter of the type which receives a disposable test strip and a sample of blood from a patient and performs an electrochemical analysis using a non-conductive integrated reagent/blood separation layer (17) containing a filler, an enzyme effective to oxidize glucose, e.g., glucose oxidase, and a mediator effective to transfer electrons from the enzyme. The integrated layer formulation is printed over a conductive carbon element (16) to form a working electrode. The filler, for example a silica filler, is selected to have a balance of hydrophobicity such that on drying it forms a two-dimensional network on the surface of the conductive element. The response of this test strip is essentially temperature independent over relevant temperature ranges and is substantially insensitive to the hematocrit of the patient.

Description

DISPOSABLE TEST STRIPS WITH INTEGRATED REAGENT/BLOOD SEPARATION LAYER
DESCRIPTION
BACKGROUND OF THE INVENTION
This application relates to disposable test strips for use in electrochemical determinations of blood analytes such as glucose, and to methods and compositions for use in making such strips. Glucose monitoring is a fact of everyday life for diabetic individuals, and the accuracy of such monitoring can literally mean the difference between life and death. To accommodate a normal life style to the need for frequent monitoring of glucose levels, a number of glucose meters are now available which permit the individual to test the glucose level in a small amount of blood. Many of these meters detect glucose in a blood sample electrochemically, by detecting the oxidation of blood glucose using an enzyme such as glucose oxidase provided as part of a disposable, single-use electrode system. Examples of devices of this type are disclosed in European Patent No. 0 127 958, and US Patents Nos. 5,141,868, 5,286,362, 5,288,636, and 5,437,999 which are incorporated herein by reference for purposes of those countries which permit such incorporation.
In general, existing glucose test strips for use in electrochemical meters comprise a substrate, working and reference electrodes formed on the surface of the substrate, and a means for making connection between the electrodes and the meter. The working electrode is coated with an enzyme capable of oxidizing glucose, and a mediator compound which transfers electrons from the enzyme to the electrode resulting in a measurable current when glucose is present. Representative mediator compounds include ferricyanide, metallocene compounds such as ferrocene, quinones, phenazinium salts, redox indicator DCPIP, and imidazole-substituted osmium compounds.
Working electrodes of this type have been formulated in a number of ways. For example, mixtures of conductive carbon, glucose oxidase and a mediator have been formulated into a paste or ink and applied to a substrate. EP 0 127 958 and US 5,286,362. In the case of disposable glucose strips, this application is done by screen printing in order to obtain the thin layers suitable for a small flat test strip. The use of screen printing, however, introduces problems to the operation of the electrode. Unlike a thicker carbon paste electrode which remains fairly intact during the measurement, screen printed electrodes formed from carbon pastes or inks are prone to break up on contact with the sample. The consequences of this breakup are two-fold. Firstly, the components of the electrode formulation are released into solution. Once these components drift more than a diffusion length away from the underlying conductive layer, they no longer contribute toward the measurement, but in fact diminish the response by depleting inwardly-diffusing analyte. Secondly, the breakup of the screen printed electrode means that the effective electrode area is falling over time.
The combination of these two effects results in current transients which fall rapidly from an initial peak over the period of the measurement, and a high sensitivity to oxygen which quickly competes with the mediator for the enzyme. This fact is clearly demonstrated by the much lower currents measured in blood samples than in plasma samples or other aqueous media, and can result in erroneous readings. A further consequence is that the transients are often "lumpy" as the electrode breaks up in a chaotic manner. Lumpy transients either give rise to erroneous readings or rejected strips, neither of which are acceptable.
In addition to the potential for electrode breakup of screen-printed carbon-based electrodes, known electrodes used in disposable glucose test strips have been kinetically-controlled, i.e., the current depends on the rate of conversion of glucose by the enzyme. Because the response measured by the instrument represents a balance between the reactions of enzyme and mediator, enzyme and glucose and enzyme and oxygen, and because each of these reactions has its own dependence on temperature, the response of a kinetically-controlled test strip is very sensitive to the temperature of the sample. Substantial variation in the measured glucose value can therefore occur as a result of variations in sample handling. A further challenge facing sensors for electrochemical glucose detection arises as a result of interference from blood cells present in the sample. The level of red blood cells is reflected in the hematocrit reading. Typically, high hematocrit samples results in readings that are lower than the true value, while low hematocrit samples result in readings that are higher because the blood cells tend to foul the surface of the electrode and limit electron transfer. Also, oxygen bound to the hemoglobin of red blood cells competes with the mediator for the reduced enzyme, thereby further diminishing the glucose response. Attempts have been made to limit the hematocrit effect by adding a membrane to filter out blood components (see, US Patent No. 5,658,444, which is incorporated herein by reference for purposes of those countries which permit such incorporation), but this adds an extra step to the manufacturing process, with associated increase in cost and often degraded performance in other areas such as precision.
Because of the importance of obtaining accurate glucose readings to the well-being of a patient using the meter and disposable test strips, it would be highly desirable to have a glucose test strip which did not suffer from these drawbacks, and which therefore provided a more consistent and reliable indication of actual blood glucose values, regardless of actual conditions. It is therefore an object of the present invention to provide disposable glucose test strips which provide a glucose reading that is essentially independent of the hematocrit of the sample, and which include an integrated reagent/blood separation layer.
It is a further object of the present invention to provide an improved method for making disposable glucose test strips.
SUMMARY OF THE INVENTION
The present invention provides an improved disposable test strip for use in a test meter of the type which receives a disposable test strip and a sample of blood from a patient and performs an electrochemical analysis of the amount of a blood analyte such as glucose in the sample. The test strip comprises: (a) a substrate;
(b) a first conductive element disposed on the substrate; (c) a second conductive element disposed on the substrate in sufficient proximity to the first conductive element to allow the completion of an electrical circuit between the first and second conductive elements when a sample of blood is placed on the test strip; (d) a non-conductive integrated reagent/blood separation layer disposed over the first conductive element; and
(e) contacts for making an electrical connection between the first and second conductive elements and the test meter. The integrated reagent/blood separation layer comprises reagents for the electrochemical detection of the analyte dispersed in a non-conductive matrix effective to exclude blood cells from the surface of the first conductive element while permitting access to the first conductive element by soluble electroactive species. In one embodiment of the invention, a glucose test strip is formed with an integrated reagent/blood separation layer comprising a filler which has both hydrophobic and hydrophilic surface regions, an enzyme effective to oxidize glucose, e.g., glucose oxidase, and a mediator effective to transfer electrons from the enzyme to the conductive element. The filler is selected to have a balance of hydrophobicity and hydrophilicity such that on drying the integrated reagent/blood separation layer forms a two-dimensional network on the surface of the conductive element. Preferred integrated reagent/blood separation layers comprise non- conductive silica fillers in combination with materials such as hydroxyethyl cellulose (HEC). The silica and HEC form a two-dimensional network which excludes red blood cells, thus rendering the test strip substantially insensitive to the hematocrit of the patient.
In a preferred embodiment of the invention, the test strips are prepared with an insulation layer disposed over at least the first conductive element. This insulation layer has an aperture formed in it which is aligned with a portion of the first conductive element, and the integrated reagent/blood separation layer is disposed to make contact with the first conductive element through this aperture. BRIEF DESCRIPTION OF THE DRAWINGS
Figs. 1A and IB show an electrode structure useful in a disposable test strip in accordance with the invention;
Fig. 2 shows a test strip in accordance with the invention; Figs. 3 A - 3C show the current measured as a function of glucose concentration for three different hematocrit levels;
Fig. 4 shows the relationship of the glucose-concentration dependence of the measured current as a function of hematocrit;
Figs. 5A - 5C show the current measured as a function of glucose in blood and a control solution for three different conductive elements;
Figs. 6A and 6B show the current measured as a function of glucose at two different temperatures;
Fig. 7 shows a further embodiment of a glucose test strip according to the invention; Figs 8 A and 8B show current transients observed using a test strip according to the invention and a commercial carbon-based test strip;
Figs. 9A-C show a three-step process for manufacture of test strips in accordance with the invention; and
Figs. 10A-10G show the manufacture of a test strip in accordance with the invention.
DETAILED DESCRIPTION OF THE INVENTION Figs. 1 A and IB show electrodes useful in a disposable test strip in accordance with the invention. As shown, the electrodes are formed on a substrate 10. On the substrate 10 are placed two conductive elements 14' and 16, connected by leads 14 and 15 to conductive contacts 11, 12, and 13. An insulating mask 18 is then formed, leaving at least a portion of conductive elements 14' and 16, and the contacts 11, 12 and 13 exposed. A non-conductive integrated reagent/blood separation layer 17 is then applied over the insulating mask 18 to make contact with conductive element 16.
SUBSTΓΓUTE SHEET (RULE 26 The assembly shown in Fig. 1 provides a fully functional assembly for the measurement of a blood analyte when connected to a meter. Advantageously, however, the electrode strips of the invention are finished by applying a nylon or polyester mesh 21 over the sample application region defined by the location of the integrated reagent/blood separation layer 17 of the electrode assembly 22, and then a top cover 23 to prevent splashing of the blood sample. (Fig. 2) The polyester mesh acts to guide the sample to the reference electrode, conductive element 14', thereby triggering the device and initiating the test.
The utilization of a non-conductive integrated reagent/blood separation layer provides an important distinction from and advantage over known test strips which utilize a conductive reagent-containing slurry to print the reagents. In these systems, the printed slurry becomes a functional part of the electrode and charge transfer can take place at the outer surface of the reagent layer. If the layer is in direct contact with blood, i.e., when no intervening separation layer has been deposited, red and white blood cells, fat and proteins present in the sample can interact with the reagent layer and interfere with the measurement of the amount of analyte in the sample.
In contrast, in the present invention, the integrated reagent/blood separation layer is non-conductive, and thus is not a part of the electrode either structurally or functionally. Charge transfer does not occur unless electroactive species pass through the openings/pores of the integrated reagent/blood separation layer to reach the underlying conductive element. Thus, the integrated reagent/blood separation layer provides a barrier to the passage of interferents such as cells and macromolecules to the conductive element resulting in a device with superior properties that is simpler to make.
In achieving this result, it is particularly desirable that the integrated reagent/blood separation layer be deposited in such a way that no portion of the conductive element 16 be directly exposed to the sample when it is placed in the sample application region. The methodology described above, in which an insulating layer with apertures providing access to the conductive elements 14' and 16 is utilized is particularly suited for achieving this result. Thus, as shown in Figs. 9A-C, this methodology allows the formation of the test strip in only three steps. In the first step (Fig. 9 A), two conductive elements 14' and 16 and associated leads and contacts are deposited on a substrate. In a second step (Fig. 9B), a layer of insulating material is deposited over the conductive elements. The insulating material has two apertures 94 and 96, one in alignment with each of the conductive elements 14' and 16. In the third step, (Fig. 9C), the integrated reagent/blood separation layer 17 is deposited over the aperture 96. By making the deposited layer 17 larger in dimensions than the aperture 96, the reagent layer completely covers the underlying conductive element such that it is not exposed directly to the sample, thereby providing effective blood separation.
The complete coverage of conductive element 16 also addresses another source of error which can occur as a result of electrochemical oxidation or small molecules such as ascorbic acid, uric acid and acetaminophen which may be present in the sample. When present, the oxidation of these molecules at the surface of the electrode leads to spuriously elevated current levels, and thus an inaccurate measurement of the desired analyte, e.g. glucose. The integrated reagent/blood separation layer of invention will not generally exclude these molecules, since they are small compared to the pore sizes observed. However, by including a pH buffer in the integrated reagent/blood separation layer one can shift the local pH at the electrode surface to a level where electrochemical potential of these species is higher.
Thus, for example, the use of an integrated reagent/blood separation layer in which the pH is buffered to a level of around pH 5 will substantially reduce the impact of these interferents. To maximize the effectiveness of this buffering, however, the entire conductive element must be covered, since even a relatively small region of exposed (not buffered) electrode surface can result in a large interference current.
Not only do the test strips of the invention provide performance benefits resulting from the separation of the conductive element from the blood sample, the test strips of the invention are also resistant to other sources of error. For example, during the period of a test, reagents may diffuse laterally away from the original deposit. If the reagent layer is deposited directly on the conductive element, these reagents will continue to contribute to the measured signal. Any variations in convective diffusion from test to test (for example as a result of differences in temperature or differences in the handling of the instrument) will therefore be manifested as irreproducibility in the signal. If the reagent layer overlaps the insulation print, however, lateral diffusion away from the aperture will not contribute to the signal and therefore will not give rise to variations in the signal.
In addition to providing a test strip with beneficial properties, the methodology outlined in Figs. 9A-C offers several advantages from a manufacturing perspective. First, if the reagent layer is printed directly onto the conductive element, the "active area" is defined by the area of the reagent layer. The precision of the test is therefore determined by the precision with which the reagent layer can be printed.
In contrast, by first depositing an apertured insulation layer defining the region of the contact between the reagent layer and the underlying conductive element, the active area is defined by the size of the aperture in the insulation layer. Since insulation layers are typically printed using a finer screen, much better edge definition, and thus greater device precision can be achieved. Thus, neither the area of conductive element 16 nor of the integrated reagent/blood separation layer are critical to the performance characteristics of the finished test strip. The conductive elements and the integrated reagent/blood separation layer may therefore be applied using techniques which provide less precision than can be employed in other processes. It will be appreciated by persons skilled in the art that, while both conductive elements must be accessible to electroactive species in a sample disposed in the sample application region, the important function of the insulation mask is to provide an aperture defining the contact region between conductive element 16 and the integrated reagent/blood separation layer 17. Thus, in the limiting case, it is only necessary to form one aperture in the insulation layer. The second conductive element can be exposed along an edge of the insulation layer, or may be located on a facing surface in a folded electrode structure.
The substrate 10 used in making the test strips of the invention can be any non-conducting, dimensionally stable material suitable for insertion into a glucose test meter. Suitable materials include polyester films, for example a 330 micron polyester film, and other insulating substrate materials such as polyvinyl chloride (PVC) and polycarbonate.
The conductive elements and associated leads and contacts can be formed from essentially any conductive material including silver, Ag/AgCl, gold, or platinum/carbon, and need not all be formed from the same material. The conductive element 16 is preferably formed from conductive carbon. Preferred conductive carbon are ERCON ERC1, ERCON ERC2 and Acheson Carbon Electrodag 423. Carbon with these specifications is available from Ercon Inc. (Waltham, Massachusetts, USA), or Acheson Colloids, (Princes Rock, Plymouth, England). The conductive element 16 makes contact with working electrode track 15, and is close to, but not contacting conductive element 14' disposed as the end of reference electrode track 14.
The insulating layer 18 can be formed from polyester-based printable dielectric materials such as ERCON R488-B(HV)-B2 Blue. The top cover 23 is suitably formed from a polyester strip or a "hot melt" coated plastic.
The test strips of the present invention do not require the formation of a discrete exit port to permit air to escape from the device as sample enters the electrode chamber but instead uses a distributed exit along all of the edges of the mesh. As the sample fluid wicks along the mesh, air seeps out of the edges of the mesh all around the device underneath the top layer. The sample fluid does not seep out because the insulation layer imparts significant hydrophobicity to that part of the mesh. The liquid sample therefore remains in the central hydrophilic region.
The key to the performance achieved using the present invention is in the nature of the integrated reagent/blood separation layer 17. This layer can be formed from a mixture containing a filler which has both hydrophobic and hydrophilic surface regions, and in the case of a glucose test strip, an enzyme which can oxidize glucose, and a mediator which can transfer electrons from the enzyme to the underlying conductive element layer 16. This layer is suitably formed by formulating an ink which contains the filler, the enzyme and the mediator in a suitable carrier and using this ink to print the layer 17 onto the device. A preferred filler for use in the layer 17 is silica. Silica is available in a variety of grades and with a variety of surface modifications. While all silica compounds tested resulted in a product which could measure glucose under some conditions, the superior performance characteristics of glucose test strip of the invention are obtained when a silica having a surface modification to render it partially hydrophobic is used. Materials of this type include Cab-O-Sil TS610, a silica which is modified by partial surface treatment with methyl dichlorosilane; Cab-o-Sil 530, a silica which is modified by full surface treatment with hexamethyl disilazane; Spherisorb C4 silica, which is surface modified with 4 carbon chains; and other similarly modified silicas, or combinations thereof. Silica with a surface modification which is too hydrophobic should be avoided. For example, it has been observed that C18-modified silica is too hydrophobic to form a printable ink.
During the process of manufacturing the ink of the invention, the particles are broken down by homogenization to expose hydrophilic inner portions of the silica particles. The actual particles present in the ink therefore have both hydrophilic and hydrophobic regions. The hydrophilic regions form hydrogen bonds with each other and with water.
When this material is formulated into an ink as described below in Example 1, and screen printed onto the conductive element 16, the dual nature of the material causes it two form layers of two-dimensional networks which take form as a kind of honeycomb which is visible upon microscopic examination . On rehydration, this layer does not break up, but swells to form a gelled reaction zone in the vicinity of the underlying conductive element 16. Reactants such as enzyme, mediator and glucose move freely within this zone, but interfering species such as red blood cells containing oxygenated hemoglobin are excluded. This results in a device in which the amount of current generated in response to a given amount of glucose varies by less than 10 percent over a hematocrit range of 40 to 60 %, and which is thus substantially insensitive to the hematocrit of the sample, and in fact performs substantially the same in blood as in a cell-free control solution. (Figs. 3A-C, Fig. 4 and Fig. 5A - 5C) Furthermore, the gelled reaction zone presents a greater barrier to entry of blood analytes such as glucose which makes the device diffusion, rather than kinetically limited. This leads to a device in which the measured current varies by less than 10 percent over a temperature range from 20°C to 37°C and which is thus essentially temperature independent. (Figs. 6A and 6B)
When making a glucose test strip, the integrated reagent/blood separation layer is advantageously formed from an aqueous composition containing 2 to 10 % by weight, preferably 4 to 10 % and more preferably about 4.5 % of a binder such as hydroxyethylcellulose or mixtures of hydroxyethylcellulose with alginate or other thickeners; 3 to 10 % by weight, preferably 3 to 5 % and more preferably about
4 % silica; 8 to 20 % by weight, preferably 14 to 18 % and more preferably about 16 % of a mediator such as ferricyanide; and .4 to 2 % by weight, preferably 1 to 2 % and more preferably about 1.6 % of an enzyme such as glucose oxidase, assuming a specific activity of about 250 units/mg, or about 1000 to 5000 units per gram of ink formulation.
The integrated reagent/blood separation layer may also include additional ingredients without departing from the scope of the invention. For example, the nonconducting layer may include an antifoam. In addition, the nonconducting layer may be formulated with a buffering agent to control the pH of the reaction zone. The pH may be maintained at a level within the range from about pH 3 to pH 10. In one embodiment of the invention, it is of particular utility to maintain the pH of the device at a level above 8 because at this pH oxygen bound to hemoglobin is not released. Further, at this pH, the reaction rate of glucose oxidase with oxygen is very low. Thus, selection of an appropriate pH can further stabilize the performance of the test strip against the effects of varying hematocrit. In an alternative embodiment of the invention, maintaining a low pH (below pH 5.5, the optimium pH for reaction of glucose oxidase with oxygen) may be preferred. For example, maintaning a pH of around pH 5 is better if the primary concern is the elimination of electrochemical interferences arising from oxidation of interfering substances such as ascorbic acid, uric acid or acetaminophen, since these compounds are more difficult to oxidize at lower pH. While a preferred embodiment of the invention is a glucose test strip as described above, the test strips of the invention are not limited to the detection of glucose. For example, a fructosamine test strip could include two layers disposed over the conductive element. The first, lower layer is formed from an ink comprising a carbonate buffer (pH>10) in a silica mix substantially as described in Example 7 but without enzyme, mediator or citrate buffer. The second, upper layer is formed form an ink further comprising an oxidant such a ferricyanide.
Fig. 7 shows an alternative embodiment of the invention. In this embodiment, a second non-conductive layer 71 is disposed over the integrated reagent/blood separation layer 17. This layer is formed from a composition which is identical to the first integrated reagent/blood separation layer except that the enzyme or both the enzyme and the mediator are omitted. This layer further isolates the conductive element 16 from contact with oxygen-carrying red blood cells, thus reducing the effects of oxygen. Furthermore, to the extent that enzyme may tend to diffuse away from the surface of the electrode during the course of the measurement, such a layer containing mediator can provide an increased region in which it will have mediator available for the transfer of electrons.
EXAMPLE 1 A non-conducting formulation for preparation of the integrated reagent/blood separation layer 17 was made as follows. 100 ml of 20 mM aqueous trisodium citrate was adjusted to pH 6 by the addition of 0.1 M citric acid. To this 6 g of hydroxyethyl cellulose (HEC) was added and mixed by homogenization. The mixture was allowed to stand overnight to allow air bubbles to disperse and then used as a stock solution for the formulation of the coating composition.
2 grams Cab-o-Sil TS610 silica and 0.1 grams of Dow Corning antifoam compound was gradually added by hand to 50 grams of the HEC solution until about 4/5 of the total amount had been added. The remainder was added with mixing by homogenization. The mixture was then cooled for ten minutes in a refrigerator. 8 g of potassium hexacyano ferrate (III) was then added and mixed until completely dissolved. Finally, 0.8 g of glucose oxidase enzyme preparation (250 Units/mg) was added and then thoroughly mixed into the solution. The resulting formulation was ready for printing, or could be stored with refrigeration.
EXAMPLE 2 To prepare glucose test strips using the ink formulation of Example 1, a series of patterns are used to screen print layers onto a 330 micron polyester substrate (Melinex 329). The first step is the printing of carbon pads. An array of 10 X 50 pads of carbon is formed on the surface of the polyester substrate by printing with EC2 carbon. (Ercon) The printed substrate is then passed through a heated dryer, and optionally cured at elevated temperature (e.g. 70 °C) for a period of 1 to 3 weeks.
Next, an array of silver/silver chloride connecting tracks and contacts is printed onto the substrate using ERCON R-414 (DPM-68)1.25 bioelectrode sensor coating material and dried. One working track which makes contact with the carbon pad and one reference track is printed for each carbon pad in the array. A dielectric layer is then printed using ERCON R488-B(HV)-B2 Blue and dried. The dielectric layer is printed in a pattern which covers substantially all of each device, leaving only the contacts, the tip of the reference electrode and the carbon pads uncovered.
On top of the dielectric layer the ink of Example 1 is used to form a integrated reagent/blood separation layer overlaid on top of each conductive carbon pad.
Polyester mesh strips (Scrynel PET230 HC) are then laid down across the substrate in lines, covering the reactions areas exposed by the windows in the dielectric. An 5 mm wide polyester strip (50 microns thick) is then applied over the top of the mesh strips, and the edges of the electrodes are heat sealed. Finally, the substrate is cut up to provide 50 individual electrodes, for example having a size of 5.5 mm wide and 30 mm long.
EXAMPLE 3 Test strips manufactured using the ink formulation of Example 1 in the manner described in Example 2 were placed in a test meter with an applied voltage of 500 mV and used to test blood samples having varying glucose concentrations and hematocrits ranging from 40% to 60%. Figs. 3A-3C show the current measured 25 seconds after applying the voltage as a function of the glucose concentration, and Fig. 4 plots the slope of the glucose response as a function of hematocrit. As can be seen, the indicators produce highly reproducible current levels which are essentially independent of hematocrit.
EXAMPLE 4 Glucose test strips in accordance with the invention were made in accordance with Example 2, except the non-conductive layer was formed with 7 g
Spherisorb C4 and 1 g Cab-o-Sil TS610. This formulation was laid down on three different types of carbon-containing conductive elements as follows:
A Ercon EC 1 B Ercon EC2 C: Ercon EC2 on top of Acheson Carbon, Electrodag 423 SS. These test strips were used to measure varying levels of glucose in either a control solution (One Touch Control Solution, Lifescan Inc.) containing glucose in an inert solution or in blood at an applied voltage of 425 mV. The current observed 25 seconds after the voltage was applied was measured. Figs. 5A - 5C show the results obtained for the three formulations, A, B, and C, respectively. In all cases, the slope of the line showing the response of the meter to different glucose concentrations was essentially the same whether the measurements were made in blood or the control solution. Thus, this further demonstrates the independence of the test strips of the invention from the oxygen content and hematocrit of the sample, as well as the ability to use various materials as the conductive element.
EXAMPLE 5
Test strips prepared in accordance with Example 2 were tested at two different sample temperatures, namely 37 °C and 20 °C using an applied voltage of 425 mV. Figs. 6A and 6B show the current measured 25 seconds after applying the voltage as a function of glucose concentration. As can be seen, the slopes of the two lines are essentially identical (0.1068 at 20 °C versus 0.1009 at 37 °C), thus demonstrating that the test strips provide essentially temperature-independent behavior over a temperature range from ambient to physiological temperatures.
EXAMPLE 6
The current transient was measured for a test strip prepared in accordance with Example 2 and for a commercial test strip made with a carbon- containing ink. The results are shown in Figs. 8A and 8B. As shown, the test strip of the invention (Fig. 8 A) provides a very flat transient which maintains more than 50% of the peak current for a period of more than 25 seconds after the initial response from the test strip. In contrast, the carbon-based electrode exhibited an almost immediate decay in the current, having lost 50% of the peak current in a period of the first 1 to 2 seconds after the initial response from the test strip. This makes timing of the measurement difficult if peak current values are to be captured, or reduces the dynamic range of the meter if current must be measured after substantial decay has occurred. Thus, the test strips of the invention are advantageous in that the current generated in response to a given amount of glucose decays by less than 50% in the 5 seconds following peak current generation.
EXAMPLE 7
An ink for printing glucose test strips in accordance with the invention was formulated as follows:
67.8 g 20 mM Citrate buffer, pH 6
0.68 g Polyvinyl alcohol (MW 85,000-146,000, 88% hydrolysed) 0.68 g of Polyvinyl pyrrolidone-vinyl acetate
0.42 g of Dow Corning DC1500 antifoam
3.4 g of hydroxyethyl cellulose (Natrosol 250G, Hercules)
5.5 g of surface modified silica (Cabo-Sil TS 610, Cabot) 1.5 g glucose oxidase 20.0 g Potassium Ferricyanide. EXAMPLE 8 Figs. 10A-I shows the stepwise preparation of a test strip in accordance with the invention. As is apparent from a comparison of this test strip and the strip of Fig. 1, the precise arrangement of the electrodes on the strip is not critical. Further, different materials may be used in fabricating the strip.
The first step in fabricating the test strip is the deposition of silver tracks 101, 102 of substrate 100. A preferred substrate is a 500 micron thick polyester film sold under the tradename Valox™. The silver electrodes can be formed by screen printing using an ink composition formulated as in Example 2. After deposition of the silver electrodes, a second electrode print is carried out to form carbon conductive elements 103, 104 and 105 as shown in Fig 10B. Conductive element 103 is formed in contact with silver track 101 and will form the working electrode in the finished test strip. Carbon pads 104 and 105 connect electrically to the ends of silver tracks 101 and 102 and provide connection between the strip and a test meter. The carbon conductive elements can be formed by screen printing with a conductive carbon ink formulation such as those described in the previous examples.
The next step in the manufacturing process is the deposition of an insulation layer 106 for example by screen printing an insulation ink, for example the dielectric ink of Example 2. ( Fig. 10C) As shown, the insulation layer contains three windows 107, 108 and 109. Window 108 is aligned with the end of the carbon conductive element 103. Window 107 is aligned with the end of silver track 102 to provide access to the reference electrode. The third window, 109, is provided to permit passage of insulation material from the second insulation coating through the mesh layer, but is not required.
Fig 10D shows the next step in the process, which is the formation of an integrated reagent/blood separation layer 110. This layer is deposited over window 108 and extends over the insulation layer 106 along all sides of the window 108. A suitable formulation for printing layer 110 has the following composition to provide an integrated reagent/blood separation layer with a buffered pH of about 6:
Figure imgf000019_0001
After the integrated reagent/blood separation layer 110 is formed, a layer of mesh 111 is deposit over the sample collection region of the test strip. (Fig. 10E) The mesh 111 is preferably a nylon mesh which has been pretreated with acetone and Fluorad FC 170C surfactant to render the mesh hydrophilic. The purpose of the mesh 111 is the transport of the liquid sample evenly through the area between the working and reference electrodes.
A second insulation print 112 is then carried out using a sllightly more flexible insulation ink (ERCON Insulayer 820202) to define the sample collection region. (Fig. 10F). A tape cover 113 is then applied over the top of the test strip as described above in Example 2 to form a finished test strip. (Fig. 10G).

Claims

L A disposable test strip for use in a test meter of the type which receives a disposable test strip and a sample of blood and performs an electrochemical analysis of the amount of a blood analyte in the sample, comprising: (a) a substrate; (b) a first conductive element disposed on the substrate; (c) a second conductive element disposed on the substrate in sufficient proximity to the first conductive element to allow the completion of an electrical circuit between the first and second conductive elements when a sample of blood is placed on the test strip; (d) a non-conductive integrated reagent/blood separation layer disposed over the first conductive element, said integrated reagent/blood separation layer comprising reagents for the electrochemical detection of the analyte dispersed in a non-conductive matrix effective to exclude blood cells from the surface of the first conductive element while permitting access to the first conductive species by soluble electroactive species; (e) contacts for making an electrical connection between the first and second conductive elements and the test meter; and (f) an insulation layer disposed over at least the first conductive elements, said insulation layer having a first aperture therein aligned with the first conductive element, wherein the non-conductive integrated reagent/blood separation layer contacts the first conductive element through the aperture in the insulation layer and wherein the non-conductive integrated reagent/blood separation layer is formed covering the entire first aperture, thereby leaving no portion of the first conductive element directly exposed to a sample applied to the test strip.
2. The test strip of claim 1, wherein the integrated reagent/blood separation layer comprises an enzyme for oxidation of glucose and a redox mediator effective to transfer electrons from the enzyme to the first conductive element.
3. The test strip of claim 2, wherein the matrix comprises silica having both hydrophobic and hydrophilic surfaces.
4. The test strip of claims 3, wherein the first and second conductive elements comprise conductive carbon.
5. The test strip according to claim 4, wherein the enzyme is glucose oxidase.
The test strip according to claim 5, wherein the redox mediator is ferricyanide.
7. The test strip according to claim 3, wherein the integrated reagent/blood separation layer is formed from an aqueous composition comprising 2 to 10 % by weight of a binder; 3 to 10 % by weight of silica; 8 to 20 % by weight of the redox mediator; and 1000 to 5000 units of the enzyme per gram of the aqueous composition.
8. The test strip of claims 7, wherein the first and second conductive elements comprise conductive carbon.
9. The test strip according to claim 7, wherein the enzyme is glucose oxidase.
10. The test strip according to claim 9, wherein the redox mediator is ferricyanide.
11. A method for forming a disposable test strip for use in a test meter of the type which receives a disposable test strip and a sample of blood and performs an electrochemical analysis of the amount of a blood analyte in the sample, comprising: (a) forming first and second conductive elements on a substrate; (b) forming a layer of insulation covering the first conductive element, said layer of insulation having a first aperture therein aligned with a portion of the first conductive element in a sample application region; and (c) forming a reagent layer disposed on the insulation layer and making contact with the first conductive element through the first aperture in the insulation layer, said integrated reagent/blood separation layer comprising reagents for the electrochemical detection of glucose dispersed in a non-conductive matrix effective to exclude blood cells from the surface of the first conductive element while permitting access to the first conductive species by soluble electroactive species, whereby the first conductive element is isolated from direct contact with a sample placed on the test strip.
12. The method of claim 11, wherein the reagent layer is a non- conductive integrated reagent/blood separation layer.
13. The method of claim 12, wherein the non-conductive integrated reagent/blood separation layer is formed covering the entire first aperture, thereby leaving no portion of the first conductive element directly exposed to a sample applied to the test strip.
14. The method of claim 13, wherein the integrated reagent/blood separation layer comprises an enzyme for oxidation of glucose and a redox mediator effective to transfer electrons from the enzyme to the first conductive element.
15. The method of claim 14, wherein the matrix is formed from silica having both hydrophobic and hydrophilic surfaces.
16. The method of claims 15, wherein the first and second conductive elements comprise conductive carbon.
17. The method of claim 16, wherein the enzyme is glucose oxidase.
18. The method of to claim 17, wherein the redox mediator is ferricyanide.
19. The method of claim 13, wherein the integrated reagent/blood separation layer is formed from an aqueous composition comprising 2 to 10 % by weight of a binder; 3 to 10 % by weight of silica; 8 to 20 % by weight of the redox mediator; and 1000 to 5000 units of the enzyme per gram of the aqueous composition.
20. The method of claims 19, wherein the first and second conductive elements comprise conductive carbon.
21. The method of claim 19, wherein the enzyme is glucose oxidase.
22. The method of claim 21 , wherein the redox mediator is ferricyanide.
23. The method of claim 13, wherein the insulation layer is formed over both the first and second conductive elements, and includes a second aperture aligned with the second conductive element.
PCT/US2000/000620 1996-02-14 2000-01-11 Disposable test strips with integrated reagent/blood separation layer WO2000042422A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
US09/869,887 US7112265B1 (en) 1996-02-14 2000-01-11 Disposable test strips with integrated reagent/blood separation layer
EP00906895A EP1155310B1 (en) 1999-01-12 2000-01-11 Disposable test strips with integrated reagent/blood separation layer
CA002358464A CA2358464C (en) 1999-01-12 2000-01-11 Disposable test strips with integrated reagent/blood separation layer
DE60025334T DE60025334T2 (en) 1999-01-12 2000-01-11 DISPOSAL TESTS WITH INTRA-GENERATED REAGENT / BLOOD SEPARATION LAYER
BRPI0008615-0A BR0008615B1 (en) 1999-01-12 2000-01-11 Disposable test strips with integrated reagent / blood separation layer and method of manufacture.
AU28479/00A AU763723B2 (en) 1999-01-12 2000-01-11 Disposable test strips with integrated reagent/blood separation layer
JP2000593945A JP3699898B2 (en) 1999-01-12 2000-01-11 Disposable test strip with integrated reagent / blood separation layer
HK02105542.0A HK1043832B (en) 1999-01-12 2002-07-29 Disposable test strips with integrated reagent/blood separation layer and method for making the same
US11/453,174 US7807031B2 (en) 1996-02-14 2006-06-13 Disposable test strips with integrated reagent/blood separation layer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/228,855 1999-01-12
US09/228,855 US6241862B1 (en) 1996-02-14 1999-01-12 Disposable test strips with integrated reagent/blood separation layer

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/228,855 Continuation-In-Part US6241862B1 (en) 1996-02-14 1999-01-12 Disposable test strips with integrated reagent/blood separation layer

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09869887 A-371-Of-International 2000-01-11
US11/453,174 Continuation US7807031B2 (en) 1996-02-14 2006-06-13 Disposable test strips with integrated reagent/blood separation layer

Publications (1)

Publication Number Publication Date
WO2000042422A1 true WO2000042422A1 (en) 2000-07-20

Family

ID=22858812

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/000620 WO2000042422A1 (en) 1996-02-14 2000-01-11 Disposable test strips with integrated reagent/blood separation layer

Country Status (13)

Country Link
US (1) US6241862B1 (en)
EP (4) EP1593958B1 (en)
JP (1) JP3699898B2 (en)
CN (1) CN1241012C (en)
AT (2) ATE458996T1 (en)
AU (1) AU763723B2 (en)
BR (1) BR0008615B1 (en)
CA (1) CA2358464C (en)
DE (2) DE60025334T2 (en)
DK (1) DK1155310T3 (en)
ES (2) ES2255980T3 (en)
HK (1) HK1043832B (en)
WO (1) WO2000042422A1 (en)

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004040289A1 (en) * 2002-11-01 2004-05-13 Arkray, Inc. Measuring instrument provided with sold component concentrating means
US7052652B2 (en) 2003-03-24 2006-05-30 Rosedale Medical, Inc. Analyte concentration detection devices and methods
US7276146B2 (en) 2001-11-16 2007-10-02 Roche Diagnostics Operations, Inc. Electrodes, methods, apparatuses comprising micro-electrode arrays
US7276147B2 (en) 2001-11-16 2007-10-02 Roche Diagnostics Operations, Inc. Method for determining the concentration of an analyte in a liquid sample using small volume samples and fast test times
WO2009021907A1 (en) * 2007-08-10 2009-02-19 Unilever Plc Disposable sensor for liquid samples
US7727467B2 (en) 2003-06-20 2010-06-01 Roche Diagnostics Operations, Inc. Reagent stripe for test strip
EP2211172A1 (en) * 2007-10-31 2010-07-28 ARKRAY, Inc. Analyzing tool, and its manufacturing method
US7794994B2 (en) 2001-11-09 2010-09-14 Kemeta, Llc Enzyme-based system and sensor for measuring acetone
US7867369B2 (en) 2003-06-20 2011-01-11 Roche Diagnostics Operations, Inc. Biosensor with multiple electrical functionalities
US7964372B2 (en) 2004-12-13 2011-06-21 Bayer Healthcare Llc Size self-limiting compositions and test devices for measuring analytes in biological fluids
US8298828B2 (en) 2003-06-20 2012-10-30 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US8679853B2 (en) 2003-06-20 2014-03-25 Roche Diagnostics Operations, Inc. Biosensor with laser-sealed capillary space and method of making
US8690796B2 (en) 2002-04-19 2014-04-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8845550B2 (en) 2001-06-12 2014-09-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8905945B2 (en) 2002-04-19 2014-12-09 Dominique M. Freeman Method and apparatus for penetrating tissue
US8919605B2 (en) 2009-11-30 2014-12-30 Intuity Medical, Inc. Calibration material delivery devices and methods
US8940153B2 (en) 2005-11-14 2015-01-27 Bayer Healthcare Llc Test sensor reagent having cellulose polymers
US8945910B2 (en) 2003-09-29 2015-02-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8969097B2 (en) 2005-06-13 2015-03-03 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit-volume correction and feedback control
US9017544B2 (en) 2002-10-04 2015-04-28 Roche Diagnostics Operations, Inc. Determining blood glucose in a small volume sample receiving cavity and in a short time period
US9034639B2 (en) 2002-12-30 2015-05-19 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US9060723B2 (en) 2005-09-30 2015-06-23 Intuity Medical, Inc. Body fluid sampling arrangements
US9072842B2 (en) 2002-04-19 2015-07-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9089294B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US9089678B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
CN104931549A (en) * 2014-03-19 2015-09-23 深圳市艾瑞生物科技有限公司 Electrochemical test paper for quantitatively measuring homocysteine and preparation method thereof
US9144401B2 (en) 2003-06-11 2015-09-29 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US9261476B2 (en) 2004-05-20 2016-02-16 Sanofi Sa Printable hydrogel for biosensors
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9351680B2 (en) 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US9386944B2 (en) 2008-04-11 2016-07-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte detecting device
US9410915B2 (en) 2004-06-18 2016-08-09 Roche Operations Ltd. System and method for quality assurance of a biosensor test strip
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9560993B2 (en) 2001-11-21 2017-02-07 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9561000B2 (en) 2003-12-31 2017-02-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
EP3156790A1 (en) * 2015-10-15 2017-04-19 ARKRAY, Inc. Biosensor and manufacturing method of biosensor
US9636051B2 (en) 2008-06-06 2017-05-02 Intuity Medical, Inc. Detection meter and mode of operation
US9782114B2 (en) 2011-08-03 2017-10-10 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9833183B2 (en) 2008-05-30 2017-12-05 Intuity Medical, Inc. Body fluid sampling device—sampling site interface
US9839386B2 (en) 2002-04-19 2017-12-12 Sanofi-Aventis Deustschland Gmbh Body fluid sampling device with capacitive sensor
WO2019016451A1 (en) 2017-07-20 2019-01-24 Lsee Electrochemical strips for monitoring the degradation of body fat and method for preparing same
US10330667B2 (en) 2010-06-25 2019-06-25 Intuity Medical, Inc. Analyte monitoring methods and systems
US10383556B2 (en) 2008-06-06 2019-08-20 Intuity Medical, Inc. Medical diagnostic devices and methods
US10433780B2 (en) 2005-09-30 2019-10-08 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
US10729386B2 (en) 2013-06-21 2020-08-04 Intuity Medical, Inc. Analyte monitoring system with audible feedback
US10772550B2 (en) 2002-02-08 2020-09-15 Intuity Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
US11933789B2 (en) 2021-05-05 2024-03-19 Intuity Medical, Inc. Calibration material delivery devices and methods

Families Citing this family (250)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112265B1 (en) * 1996-02-14 2006-09-26 Lifescan Scotland Limited Disposable test strips with integrated reagent/blood separation layer
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US8071384B2 (en) 1997-12-22 2011-12-06 Roche Diagnostics Operations, Inc. Control and calibration solutions and methods for their use
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US6554798B1 (en) 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US6413394B1 (en) * 1999-07-08 2002-07-02 Thomas Y. Shen Disposable plate electrode with biological active film
US20050103624A1 (en) 1999-10-04 2005-05-19 Bhullar Raghbir S. Biosensor and method of making
JP4601809B2 (en) * 2000-12-11 2010-12-22 パナソニック株式会社 Biosensor and substrate measurement method
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US6576102B1 (en) 2001-03-23 2003-06-10 Virotek, L.L.C. Electrochemical sensor and method thereof
US6572745B2 (en) * 2001-03-23 2003-06-03 Virotek, L.L.C. Electrochemical sensor and method thereof
US7041468B2 (en) 2001-04-02 2006-05-09 Therasense, Inc. Blood glucose tracking apparatus and methods
ATE485766T1 (en) 2001-06-12 2010-11-15 Pelikan Technologies Inc ELECTRICAL ACTUATING ELEMENT FOR A LANCET
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
WO2002100254A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
ATE497731T1 (en) 2001-06-12 2011-02-15 Pelikan Technologies Inc DEVICE FOR INCREASING THE SUCCESS RATE OF BLOOD YIELD OBTAINED BY A FINGER PICK
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7316700B2 (en) 2001-06-12 2008-01-08 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
CA2448905C (en) 2001-06-12 2010-09-07 Pelikan Technologies, Inc. Blood sampling apparatus and method
AT410223B (en) * 2001-08-09 2003-03-25 Adlassnig Alexander Mag Dr BIOSENSORS IN THICK FILM TECHNOLOGY
ES2266559T3 (en) * 2001-09-24 2007-03-01 Atsuo F. Fukunaga RESPIRATORY CIRCUITS THAT HAVE CONVENTIONS AND UNCONVENTIONAL RESPSIRATORY SYSTEMS AND PROCEDURES TO OPTIMIZE THE USE OF PURE GASES.
US6997343B2 (en) * 2001-11-14 2006-02-14 Hypoguard Limited Sensor dispensing device
US6723500B2 (en) 2001-12-05 2004-04-20 Lifescan, Inc. Test strips having reaction zones and channels defined by a thermally transferred hydrophobic barrier
US20030111357A1 (en) * 2001-12-13 2003-06-19 Black Murdo M. Test meter calibration
CA2471018A1 (en) * 2002-01-28 2003-08-07 Burstein Technologies, Inc. Methods and apparatus for logical triggering of an optical bio-disc
CA2471017A1 (en) * 2002-01-31 2003-08-07 Burstein Technologies, Inc. Method for triggering through disc grooves and related optical analysis discs and system
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US20030212379A1 (en) * 2002-02-26 2003-11-13 Bylund Adam David Systems and methods for remotely controlling medication infusion and analyte monitoring
EP1482307B1 (en) * 2002-03-01 2007-10-03 Matsushita Electric Industrial Co., Ltd. Biosensor
US20030169426A1 (en) * 2002-03-08 2003-09-11 Peterson Timothy A. Test member orientation
US20030186446A1 (en) 2002-04-02 2003-10-02 Jerry Pugh Test strip containers and methods of using the same
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) * 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US6743635B2 (en) 2002-04-25 2004-06-01 Home Diagnostics, Inc. System and methods for blood glucose sensing
US6946299B2 (en) * 2002-04-25 2005-09-20 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US6964871B2 (en) * 2002-04-25 2005-11-15 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US20080112852A1 (en) * 2002-04-25 2008-05-15 Neel Gary T Test Strips and System for Measuring Analyte Levels in a Fluid Sample
US7303726B2 (en) * 2002-05-09 2007-12-04 Lifescan, Inc. Minimal procedure analyte test system
US7250095B2 (en) * 2002-07-11 2007-07-31 Hypoguard Limited Enzyme electrodes and method of manufacture
AU2003269635A1 (en) * 2002-09-20 2004-04-08 Medinnov, Inc. An analyzer for the simultaneous enzymatic detection of closely related analytes
US20050049522A1 (en) * 2002-10-30 2005-03-03 Allen John J Method of lancing skin for the extraction of blood
US7842234B2 (en) 2002-12-02 2010-11-30 Epocal Inc. Diagnostic devices incorporating fluidics and methods of manufacture
US7767068B2 (en) * 2002-12-02 2010-08-03 Epocal Inc. Heterogeneous membrane electrodes
US7175897B2 (en) * 2002-12-17 2007-02-13 Avery Dennison Corporation Adhesive articles which contain at least one hydrophilic or hydrophobic layer, method for making and uses for same
EP1578262A4 (en) 2002-12-31 2007-12-05 Therasense Inc Continuous glucose monitoring system and methods of use
US7144485B2 (en) * 2003-01-13 2006-12-05 Hmd Biomedical Inc. Strips for analyzing samples
GB0300820D0 (en) * 2003-01-14 2003-02-12 Diagnoswiss Sa Membrane-microchannel strip
US7264139B2 (en) * 2003-01-14 2007-09-04 Hypoguard Limited Sensor dispensing device
US20040163987A1 (en) 2003-02-25 2004-08-26 John Allen Automatically opening medical device package and method of manufacture
CN100346746C (en) * 2003-03-06 2007-11-07 生命扫描有限公司 System and method for piercing dermal tissue
US20040193202A1 (en) * 2003-03-28 2004-09-30 Allen John J. Integrated lance and strip for analyte measurement
US7473264B2 (en) * 2003-03-28 2009-01-06 Lifescan, Inc. Integrated lance and strip for analyte measurement
US20040193072A1 (en) * 2003-03-28 2004-09-30 Allen John J. Method of analyte measurement using integrated lance and strip
US7587287B2 (en) 2003-04-04 2009-09-08 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
ATE476137T1 (en) 2003-05-30 2010-08-15 Pelikan Technologies Inc METHOD AND DEVICE FOR INJECTING LIQUID
WO2004107964A2 (en) 2003-06-06 2004-12-16 Pelikan Technologies, Inc. Blood harvesting device with electronic control
KR100554649B1 (en) * 2003-06-09 2006-02-24 주식회사 아이센스 Electrochemical biosensor
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8058077B2 (en) 2003-06-20 2011-11-15 Roche Diagnostics Operations, Inc. Method for coding information on a biosensor test strip
US7488601B2 (en) 2003-06-20 2009-02-10 Roche Diagnostic Operations, Inc. System and method for determining an abused sensor during analyte measurement
US7718439B2 (en) 2003-06-20 2010-05-18 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US8206565B2 (en) 2003-06-20 2012-06-26 Roche Diagnostics Operation, Inc. System and method for coding information on a biosensor test strip
US7452457B2 (en) 2003-06-20 2008-11-18 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US8071030B2 (en) 2003-06-20 2011-12-06 Roche Diagnostics Operations, Inc. Test strip with flared sample receiving chamber
US7645421B2 (en) 2003-06-20 2010-01-12 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US7645373B2 (en) 2003-06-20 2010-01-12 Roche Diagnostic Operations, Inc. System and method for coding information on a biosensor test strip
US20050019211A1 (en) * 2003-07-24 2005-01-27 Ching-Ho Lien Test strip for examination liquid test sample
US20140121989A1 (en) 2003-08-22 2014-05-01 Dexcom, Inc. Systems and methods for processing analyte sensor data
JP2007510155A (en) * 2003-10-29 2007-04-19 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ Biosensor
EP1680175B1 (en) * 2003-11-06 2019-06-05 LifeScan, Inc. Drug delivery pen with event notification means
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US20050150763A1 (en) * 2004-01-09 2005-07-14 Butters Colin W. Biosensor and method of manufacture
US7384791B2 (en) * 2004-01-21 2008-06-10 Hewlett-Packard Development Company, L.P. Method of analyzing blood
BRPI0507376A (en) 2004-02-06 2007-07-10 Bayer Healthcare Llc oxidizable species as an internal reference for biosensors and method of use
WO2005089103A2 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US20050187525A1 (en) * 2004-02-19 2005-08-25 Hilgers Michael E. Devices and methods for extracting bodily fluid
US7807043B2 (en) * 2004-02-23 2010-10-05 Oakville Hong Kong Company Limited Microfluidic test device
US7118667B2 (en) * 2004-06-02 2006-10-10 Jin Po Lee Biosensors having improved sample application and uses thereof
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US20050284773A1 (en) 2004-06-29 2005-12-29 Allen John J Method of preventing reuse in an analyte measuring system
US20050284757A1 (en) * 2004-06-29 2005-12-29 Allen John J Analyte measuring system which prevents the reuse of a test strip
WO2006042304A1 (en) * 2004-10-12 2006-04-20 Bayer Healthcare Llc Concentration determination in a diffusion barrier layer
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
RU2422534C2 (en) * 2005-03-04 2011-06-27 Байер Хелткэр Ллк Enzyme stabilisation in electrochemical biosensors
US7713392B2 (en) * 2005-04-15 2010-05-11 Agamatrix, Inc. Test strip coding and quality measurement
US7964089B2 (en) 2005-04-15 2011-06-21 Agamatrix, Inc. Analyte determination method and analyte meter
US20060243591A1 (en) * 2005-04-28 2006-11-02 Plotkin Elliot V Electrochemical-based analytical test strip with hydrophilicity enhanced metal electrodes
US20060246214A1 (en) * 2005-04-28 2006-11-02 Plotkin Elliot V Method for manufacturing an electrochemical-based analytical test strip with hydrophilicity enhanced metal electrodes
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US7695600B2 (en) * 2005-06-03 2010-04-13 Hypoguard Limited Test system
GB0511270D0 (en) 2005-06-03 2005-07-13 Hypoguard Ltd Test system
US7922883B2 (en) 2005-06-08 2011-04-12 Abbott Laboratories Biosensors and methods of using the same
US7905999B2 (en) * 2005-06-08 2011-03-15 Abbott Laboratories Biosensor strips and methods of preparing same
AU2006272909B2 (en) 2005-07-20 2013-02-07 Bayer Healthcare Llc Gated amperometry
KR101477815B1 (en) 2005-09-30 2015-01-02 바이엘 헬스케어 엘엘씨 Gated voltammetry
US7468125B2 (en) * 2005-10-17 2008-12-23 Lifescan, Inc. System and method of processing a current sample for calculating a glucose concentration
US8066866B2 (en) * 2005-10-17 2011-11-29 Lifescan, Inc. Methods for measuring physiological fluids
EP1780541B1 (en) * 2005-10-25 2008-10-15 F.Hoffmann-La Roche Ag Analysis device for analysing a sample on a test element
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7811430B2 (en) * 2006-02-28 2010-10-12 Abbott Diabetes Care Inc. Biosensors and methods of making
GB2436616A (en) * 2006-03-29 2007-10-03 Inverness Medical Switzerland Assay device and method
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US20070235346A1 (en) * 2006-04-11 2007-10-11 Popovich Natasha D System and methods for providing corrected analyte concentration measurements
US20080071158A1 (en) 2006-06-07 2008-03-20 Abbott Diabetes Care, Inc. Analyte monitoring system and method
US9046480B2 (en) 2006-10-05 2015-06-02 Lifescan Scotland Limited Method for determining hematocrit corrected analyte concentrations
EP2437056B1 (en) 2006-10-05 2013-11-20 Lifescan Scotland Ltd Methods for determining the presence of a sufficient quantity of fluid sample on a test strip
EP2074415A1 (en) * 2006-10-05 2009-07-01 Lifescan Scotland Limited A test strip comprising patterned electrodes
ES2375288T3 (en) * 2006-10-05 2012-02-28 Lifescan Scotland Limited PROCEDURE TO DETERMINE ANALYTE CONCENTRATIONS CORRECTED WITH HEMATOCRITE.
EP2080022B1 (en) * 2006-10-05 2015-05-13 Lifescan Scotland Ltd Methods for determining an analyte concentration using signal processing algorithms
BRPI0717620A2 (en) 2006-10-24 2013-10-22 Bayer Healthcare Llc TRANSITIONAL DECAY AMPEROMETRY
US20080124693A1 (en) * 2006-10-26 2008-05-29 Mcevoy Mary System for determining an analyte in a bodily fluid sample that includes a graphics-based step-by-step tutorial module
US20080164142A1 (en) 2006-10-27 2008-07-10 Manuel Alvarez-Icaza Surface treatment of carbon composite material to improve electrochemical properties
WO2008079731A1 (en) * 2006-12-22 2008-07-03 Home Diagnostics, Inc. Gel formation to reduce hematocrit sensitivity in electrochemical test
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
EP2053241A1 (en) 2007-10-24 2009-04-29 Ecotecnia Energias Renovables S.L. Method for determining fatigue damage in a power train of a wind turbine
WO2009076302A1 (en) 2007-12-10 2009-06-18 Bayer Healthcare Llc Control markers for auto-detection of control solution and methods of use
US20090208734A1 (en) * 2008-01-18 2009-08-20 Macfie Gavin Test strips, methods, and system of manufacturing test strip lots having a predetermined calibration characteristic
EP2241883A4 (en) 2008-01-22 2014-10-29 Univ Nat Chonnam Ind Found Method and apparatus for estimating features of target materials by using kinetic change information
IL197532A0 (en) 2008-03-21 2009-12-24 Lifescan Scotland Ltd Analyte testing method and system
US8178313B2 (en) 2008-06-24 2012-05-15 Lifescan, Inc. Method for determining an analyte in a bodily fluid
US7922985B2 (en) 2008-06-24 2011-04-12 Lifescan, Inc. Analyte test strip for accepting diverse sample volumes
US8187658B2 (en) 2008-06-24 2012-05-29 Lifescan, Inc. Method of manufacturing analyte test strip for accepting diverse sample volumes
CN101315345B (en) * 2008-07-15 2011-09-28 四川大学 Production method for Modified electrode for detecting grape-sugar concentration in non-enzyme condition
TWM346412U (en) * 2008-08-01 2008-12-11 Biomedix Taiwan Co Ltd Biochemical sensor
BRPI0913784A2 (en) * 2008-09-30 2015-10-20 Menai Medical Technologies Ltd "sample measurement system, sampling plate, measuring device, adapter, data charger, sampling plate production method, continuous sheet production method, continuous sheet, apparatus, method for testing a medical condition, and , diagnostic kit to test a medical condition "
EP2361427A1 (en) * 2008-10-27 2011-08-31 Lifescan Scotland Limited Methods and devices for mitigating esd events
US8012428B2 (en) 2008-10-30 2011-09-06 Lifescan Scotland, Ltd. Analytical test strip with minimal fill-error sample viewing window
US20100112612A1 (en) * 2008-10-30 2010-05-06 John William Dilleen Method for determining an analyte using an analytical test strip with a minimal fill-error viewing window
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
KR101032691B1 (en) * 2009-04-17 2011-05-06 (주)디지탈옵틱 Biosensor for the use of diagnosis that prompt blood separation is possible
US20100273249A1 (en) * 2009-04-24 2010-10-28 Lifescan Scotland Limited Analytical test strips
US8025788B2 (en) * 2009-04-24 2011-09-27 Lifescan Scotland Limited Method for manufacturing an enzymatic reagent ink
WO2010127050A1 (en) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US20100326824A1 (en) 2009-06-24 2010-12-30 Lifescan, Inc. Analyte test strip with combination electrode contact and meter identification feature
US8173008B2 (en) 2009-06-24 2012-05-08 Lifescan, Inc. Method for determining an analyte in a bodily fluid sample using an analyte test strip with combination electrode contact and meter identification feature
WO2011012848A1 (en) 2009-07-27 2011-02-03 Suresensors Ltd Improvements relating to sensor devices
US20110048972A1 (en) * 2009-08-31 2011-03-03 Lifescan Scotland Limited Multi-analyte test strip with shared counter/reference electrode and inline electrode configuration
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
EP2473098A4 (en) 2009-08-31 2014-04-09 Abbott Diabetes Care Inc Analyte signal processing device and methods
EP2634572B1 (en) 2009-09-04 2018-05-02 Lifescan Scotland Limited Method for determining a hematocrit-corrected test current in glucose measurements
US20110057671A1 (en) 2009-09-04 2011-03-10 Lifescan Scotland, Ltd. Methods, system and device to identify a type of test strip
WO2011041469A1 (en) 2009-09-29 2011-04-07 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US8545693B2 (en) * 2009-09-29 2013-10-01 Lifescan Scotland Limited Analyte measurment method and system
US20110079522A1 (en) 2009-10-02 2011-04-07 Lifescan Scotland Limited Multi-analyte test strip with inline working electrodes and shared opposing counter/reference electrode
US8323467B2 (en) 2009-10-27 2012-12-04 Lifescan Scotland Limited Dual chamber, multi-analyte test strip with opposing electrodes
US8632664B2 (en) 2009-10-27 2014-01-21 Lifescan Scotland Limited Test meter for use with a dual chamber, multi-analyte test strip with opposing electrodes
US8877034B2 (en) * 2009-12-30 2014-11-04 Lifescan, Inc. Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity
US8101065B2 (en) 2009-12-30 2012-01-24 Lifescan, Inc. Systems, devices, and methods for improving accuracy of biosensors using fill time
GB201005359D0 (en) 2010-03-30 2010-05-12 Menai Medical Technologies Ltd Sampling plate
GB201005357D0 (en) 2010-03-30 2010-05-12 Menai Medical Technologies Ltd Sampling plate
EP2553441B1 (en) 2010-03-31 2019-10-23 Lifescan Scotland Limited Electrochemical analyte measurement method and system
CN103002795A (en) * 2010-05-09 2013-03-27 拉布斯戴尔创新有限公司 Fluids testing apparatus and methods of use
US8940141B2 (en) 2010-05-19 2015-01-27 Lifescan Scotland Limited Analytical test strip with an electrode having electrochemically active and inert areas of a predetermined size and distribution
US20110290668A1 (en) 2010-05-27 2011-12-01 Lifescan Scotland Limited Analytical test strip with crossroads exposed electrode configuration
US8239582B2 (en) 2010-05-27 2012-08-07 Cilag Gmbh International Hand-held test meter with disruption avoidance circuitry
US20110315564A1 (en) 2010-06-28 2011-12-29 Cilag Gmbh International Hand-held test meter with deep power conservation mode
US8409412B2 (en) 2010-08-23 2013-04-02 Lifescan Scotland, Ltd. Enzymatic reagent inks for use in test strips having a predetermined calibration code
US20120048746A1 (en) 2010-08-30 2012-03-01 Cilag Gmbh International Analyte test strip with electrically distinguishable divided electrode
ES2747388T3 (en) 2010-09-13 2020-03-10 Lifescan Scotland Ltd Procedure and measurement system for analytes with hematocrit compensation
AU2011309958B2 (en) 2010-09-28 2015-11-26 Lifescan Scotland Limited Glucose electrochemical measurement method with error detection
US8932445B2 (en) 2010-09-30 2015-01-13 Cilag Gmbh International Systems and methods for improved stability of electrochemical sensors
US8617370B2 (en) 2010-09-30 2013-12-31 Cilag Gmbh International Systems and methods of discriminating between a control sample and a test fluid using capacitance
US20130229288A1 (en) 2010-11-15 2013-09-05 Lifescan Scotland Limited Server-side initiated communication with analyte meter-side completed data transfer
TWI438425B (en) * 2011-01-18 2014-05-21 Eps Bio Technology Corp Method for making an electrochemical sensor strip
US8486717B2 (en) 2011-01-18 2013-07-16 Symbolics, Llc Lateral flow assays using two dimensional features
US20120199498A1 (en) 2011-02-07 2012-08-09 Manuel Alvarez-Icaza Electrochemical-based analytical test strip with graded enzymatic reagent layer and related methods
SG10201403559UA (en) * 2011-02-28 2014-10-30 Aytu Bioscience Inc Method and apparatus for measuring oxidation-reduction potential
WO2012177114A1 (en) * 2011-06-20 2012-12-27 Mimos Berhad Analyte sensor system
US20130006536A1 (en) 2011-06-28 2013-01-03 Lifescan, Inc. Hand-held test meter with unpowered usb connection detection circuit
US20130002266A1 (en) 2011-06-28 2013-01-03 Lifescan, Inc. Hand-held test meter with electromagnetic interference detection circuit
US8475733B2 (en) 2011-08-04 2013-07-02 Cilag Gmbh International Hand-held test meter and analytical test strip cartridge assembly with desiccant vial
US8580576B2 (en) 2011-08-04 2013-11-12 Cilag Gmbh International Method for bodily fluid sample transfer during analyte determination
US8603309B2 (en) 2011-09-12 2013-12-10 Nova Biomedical Corporation Disposable sensor for electrochemical detection of hemoglobin
US20130084591A1 (en) 2011-09-30 2013-04-04 Lifescan Scotland Ltd. Analytical test strip with isolated bodily fluid phase-shift and analyte determination sample chambers
US20130084590A1 (en) 2011-09-30 2013-04-04 Lifescan Scotland Ltd. Analytical test strip with bodily fluid phase-shift measurement electrodes
US20130098775A1 (en) * 2011-10-20 2013-04-25 Nova Biomedical Corporation Glucose biosensor with improved shelf life
WO2013070794A2 (en) 2011-11-07 2013-05-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods
KR101367262B1 (en) 2011-11-11 2014-02-26 주식회사 아이센스 Blood Glucose Sensor and sensing error detecting method using thereof
US9572922B2 (en) 2012-12-21 2017-02-21 Larry Leonard Inventive diabetic systems, tools, kits, and supplies for better diabetic living and mobility
CN103175872A (en) * 2011-12-23 2013-06-26 长沙中生众捷生物技术有限公司 Portable electrochemical detection test strip and preparation method thereof
US9903830B2 (en) 2011-12-29 2018-02-27 Lifescan Scotland Limited Accurate analyte measurements for electrochemical test strip based on sensed physical characteristic(s) of the sample containing the analyte
US20130189769A1 (en) * 2012-01-21 2013-07-25 Rapha Bio Ltd. Biochemical sensor
JP6489418B2 (en) 2012-01-24 2019-03-27 ミニケア ビー.ブイ. Filter unit for cartridge
US20130199942A1 (en) 2012-02-07 2013-08-08 Lifescan Scotland Limited Electrochemical-based analytical test strip with fill-speed configured reagent layer
US20130220835A1 (en) 2012-02-29 2013-08-29 Lifescan Scotland Limited Polymeric vdat nanoparticles for use in biosensors
SG11201406203UA (en) * 2012-04-19 2014-11-27 Aytu Bioscience Inc Multiple layer gel
US20130284609A1 (en) 2012-04-30 2013-10-31 Lifescan Scotland Limited Enzymatic electrochemical-based sensors with nad polymeric coenzyme
US9465910B2 (en) 2012-05-15 2016-10-11 James Minor Diagnostic methods and devices for monitoring chronic glycemia
US11798685B2 (en) 2012-05-15 2023-10-24 James M. Minor Diagnostic methods and devices for controlling acute glycemia
KR101466222B1 (en) 2012-06-01 2014-12-01 주식회사 아이센스 Electrochemical biosensor with improved accuracy
US8877023B2 (en) 2012-06-21 2014-11-04 Lifescan Scotland Limited Electrochemical-based analytical test strip with intersecting sample-receiving chambers
US20130341207A1 (en) 2012-06-21 2013-12-26 Lifescan Scotland Limited Analytical test strip with capillary sample-receiving chambers separated by stop junctions
US9128038B2 (en) 2012-06-21 2015-09-08 Lifescan Scotland Limited Analytical test strip with capillary sample-receiving chambers separated by a physical barrier island
TWM442505U (en) * 2012-07-06 2012-12-01 Ok Biotech Co Ltd Biological inspection testpiece
US9874556B2 (en) 2012-07-18 2018-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9211087B2 (en) 2012-10-18 2015-12-15 Animas Corporation Self-contained hand-held test device for single-use
EP2885636B1 (en) 2012-10-23 2018-02-14 Aytu BioScience, Inc. Methods and systems for measuring oxidation-reduction potential of a biological sample
GB2510371B (en) * 2013-01-31 2016-01-06 Lifescan Scotland Ltd Electrochemical-based analytical test strip with soluble acidic material coating
US9157883B2 (en) 2013-03-07 2015-10-13 Lifescan Scotland Limited Methods and systems to determine fill direction and fill error in analyte measurements
US10371660B2 (en) 2013-05-17 2019-08-06 Lifescan Ip Holdings, Llc Accurate analyte measurements for electrochemical test strip based on multiple calibration parameters
GB2514846B (en) 2013-06-07 2015-09-30 Lifescan Scotland Ltd Electrochemical-based analytical test strip with a soluble electrochemically-active coating opposite a bare electrode
US10545132B2 (en) * 2013-06-25 2020-01-28 Lifescan Ip Holdings, Llc Physiological monitoring system communicating with at least a social network
US9243276B2 (en) 2013-08-29 2016-01-26 Lifescan Scotland Limited Method and system to determine hematocrit-insensitive glucose values in a fluid sample
US9459231B2 (en) 2013-08-29 2016-10-04 Lifescan Scotland Limited Method and system to determine erroneous measurement signals during a test measurement sequence
WO2015038978A1 (en) 2013-09-13 2015-03-19 Symbolics, Llc Lateral flow assays using two dimensional test and control signal readout patterns
US9453812B2 (en) 2014-06-24 2016-09-27 Lifescan Scotland Limited End-fill electrochemical-based analytical test strip with perpendicular intersecting sample-receiving chambers
US20150369813A1 (en) * 2014-06-24 2015-12-24 Lifescan Scotland Limited Analytical test strip with tiered capillary chamber
US20160091450A1 (en) 2014-09-25 2016-03-31 Lifescan Scotland Limited Accurate analyte measurements for electrochemical test strip to determine analyte measurement time based on measured temperature, physical characteristic and estimated analyte value and their temperature compensated values
US20160091451A1 (en) 2014-09-25 2016-03-31 Lifescan Scotland Limited Accurate analyte measurements for electrochemical test strip to determine analyte measurement time based on measured temperature, physical characteristic and estimated analyte value
GB2549281A (en) * 2016-04-11 2017-10-18 Palintest Ltd Electrochemical sensor
US20200064351A1 (en) * 2017-05-05 2020-02-27 Analytical Diagnostic Solutions, Inc. Point-of-care device for the quantitative determination of branched-chain amino acids in biological samples
US20190094170A1 (en) 2017-09-22 2019-03-28 Cilag Gmbh International Analytical test strip with integrated electrical resistor
US10293340B2 (en) 2017-10-11 2019-05-21 Fitbit, Inc. Microfluidic metering and delivery system
CN112251069A (en) * 2020-10-29 2021-01-22 郑州百瑞动物药业有限公司 Enzyme ink for enzyme electrode based on water-based screen printing technology and preparation method thereof
CN114923965B (en) * 2022-03-18 2023-05-23 杭州微策生物技术股份有限公司 Integrated multi-index sensor and manufacturing method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0207370A2 (en) * 1985-06-28 1987-01-07 Miles Inc. Electrochemical sensor and membrane therefor
US5185256A (en) * 1985-06-21 1993-02-09 Matsushita Electric Industrial Co., Ltd. Method for making a biosensor
US5601694A (en) * 1994-06-27 1997-02-11 Ciba Corning Diagnostics Corp. Electrochemical sensors

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195129A (en) 1975-11-26 1980-03-25 Kansai Paint Co., Ltd. Method for immobilizing enzymes and microbial cells
US4418148A (en) 1981-11-05 1983-11-29 Miles Laboratories, Inc. Multilayer enzyme electrode membrane
CA1226036A (en) 1983-05-05 1987-08-25 Irving J. Higgins Analytical equipment and sensor electrodes therefor
US4655880A (en) 1983-08-01 1987-04-07 Case Western Reserve University Apparatus and method for sensing species, substances and substrates using oxidase
AU581669B2 (en) * 1984-06-13 1989-03-02 Applied Research Systems Ars Holding N.V. Photometric instruments, their use in methods of optical analysis, and ancillary devices therefor
US5141868A (en) 1984-06-13 1992-08-25 Internationale Octrooi Maatschappij "Octropa" Bv Device for use in chemical test procedures
GB8526902D0 (en) 1985-10-31 1985-12-04 Unilever Plc Electrochemical analysis
GB8619627D0 (en) 1986-08-12 1986-09-24 Genetics Int Inc Electrochemical assay
US4759828A (en) * 1987-04-09 1988-07-26 Nova Biomedical Corporation Glucose electrode and method of determining glucose
GB8709882D0 (en) * 1987-04-27 1987-06-03 Genetics Int Inc Membrane configurations
US5128015A (en) 1988-03-15 1992-07-07 Tall Oak Ventures Method and apparatus for amperometric diagnostic analysis
DE68924026T3 (en) 1988-03-31 2008-01-10 Matsushita Electric Industrial Co., Ltd., Kadoma BIOSENSOR AND ITS MANUFACTURE.
GB8817421D0 (en) 1988-07-21 1988-08-24 Medisense Inc Bioelectrochemical electrodes
GB8822738D0 (en) 1988-09-28 1988-11-02 Medisense Inc Theophylline assay
US5264106A (en) 1988-10-07 1993-11-23 Medisense, Inc. Enhanced amperometric sensor
US5262035A (en) 1989-08-02 1993-11-16 E. Heller And Company Enzyme electrodes
AU634863B2 (en) 1989-12-15 1993-03-04 Roche Diagnostics Operations Inc. Redox mediator reagent and biosensor
US5286362A (en) 1990-02-03 1994-02-15 Boehringer Mannheim Gmbh Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor
FR2673289B1 (en) 1991-02-21 1994-06-17 Asulab Sa SENSOR FOR MEASURING THE QUANTITY OF A COMPONENT IN SOLUTION.
GB9309797D0 (en) * 1993-05-12 1993-06-23 Medisense Inc Electrochemical sensors
US5762770A (en) * 1994-02-21 1998-06-09 Boehringer Mannheim Corporation Electrochemical biosensor test strip
US5437999A (en) 1994-02-22 1995-08-01 Boehringer Mannheim Corporation Electrochemical sensor
AUPN363995A0 (en) * 1995-06-19 1995-07-13 Memtec Limited Electrochemical cell
US5628890A (en) * 1995-09-27 1997-05-13 Medisense, Inc. Electrochemical sensor
US5708247A (en) * 1996-02-14 1998-01-13 Selfcare, Inc. Disposable glucose test strips, and methods and compositions for making same
EP0958495B1 (en) * 1997-02-06 2002-11-13 Therasense, Inc. Small volume in vitro analyte sensor
CO5040209A1 (en) * 1997-10-16 2001-05-29 Abbott Lab BIOSENSOR ELECTRODES MEDIATORS OF COFACTOR REGENERATION

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185256A (en) * 1985-06-21 1993-02-09 Matsushita Electric Industrial Co., Ltd. Method for making a biosensor
EP0207370A2 (en) * 1985-06-28 1987-01-07 Miles Inc. Electrochemical sensor and membrane therefor
US5601694A (en) * 1994-06-27 1997-02-11 Ciba Corning Diagnostics Corp. Electrochemical sensors

Cited By (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9694144B2 (en) 2001-06-12 2017-07-04 Sanofi-Aventis Deutschland Gmbh Sampling module device and method
US9802007B2 (en) 2001-06-12 2017-10-31 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US8845550B2 (en) 2001-06-12 2014-09-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7794994B2 (en) 2001-11-09 2010-09-14 Kemeta, Llc Enzyme-based system and sensor for measuring acetone
US10386322B2 (en) 2001-11-16 2019-08-20 Roche Diabetes Care, Inc. Method for determining the concentration of an analyte in a liquid sample using small volume samples and fast test times
US7276146B2 (en) 2001-11-16 2007-10-02 Roche Diagnostics Operations, Inc. Electrodes, methods, apparatuses comprising micro-electrode arrays
US7276147B2 (en) 2001-11-16 2007-10-02 Roche Diagnostics Operations, Inc. Method for determining the concentration of an analyte in a liquid sample using small volume samples and fast test times
US9658183B2 (en) 2001-11-16 2017-05-23 Roche Diabetes Care, Inc. Method for determining the concentration of an analyte in a liquid sample using small volume samples and fast test times
US9560993B2 (en) 2001-11-21 2017-02-07 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US10772550B2 (en) 2002-02-08 2020-09-15 Intuity Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
US9089678B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8905945B2 (en) 2002-04-19 2014-12-09 Dominique M. Freeman Method and apparatus for penetrating tissue
US9498160B2 (en) 2002-04-19 2016-11-22 Sanofi-Aventis Deutschland Gmbh Method for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9186468B2 (en) 2002-04-19 2015-11-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9089294B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US9839386B2 (en) 2002-04-19 2017-12-12 Sanofi-Aventis Deustschland Gmbh Body fluid sampling device with capacitive sensor
US9072842B2 (en) 2002-04-19 2015-07-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8690796B2 (en) 2002-04-19 2014-04-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9724021B2 (en) 2002-04-19 2017-08-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9017544B2 (en) 2002-10-04 2015-04-28 Roche Diagnostics Operations, Inc. Determining blood glucose in a small volume sample receiving cavity and in a short time period
US10408784B2 (en) 2002-10-04 2019-09-10 Roche Diabetes Care, Inc. Determining blood glucose in a small volume sample receiving cavity and in a short time period
US9638658B2 (en) 2002-10-04 2017-05-02 Roche Diabetes Care, Inc. Determining blood glucose in a small volume sample receiving cavity and in a short time period
US7201042B2 (en) 2002-11-01 2007-04-10 Arkray, Inc. Measuring instrument provided with solid component concentrating means
WO2004040289A1 (en) * 2002-11-01 2004-05-13 Arkray, Inc. Measuring instrument provided with sold component concentrating means
US9034639B2 (en) 2002-12-30 2015-05-19 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US9095292B2 (en) 2003-03-24 2015-08-04 Intuity Medical, Inc. Analyte concentration detection devices and methods
US7427377B2 (en) 2003-03-24 2008-09-23 Intuity Medical, Inc. Analyte concentration detection devices and methods
US7052652B2 (en) 2003-03-24 2006-05-30 Rosedale Medical, Inc. Analyte concentration detection devices and methods
US9144401B2 (en) 2003-06-11 2015-09-29 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US10034628B2 (en) 2003-06-11 2018-07-31 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US8586373B2 (en) 2003-06-20 2013-11-19 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US8298828B2 (en) 2003-06-20 2012-10-30 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US7749437B2 (en) 2003-06-20 2010-07-06 Roche Diagnostics Operations, Inc. Method and reagent for producing narrow, homogenous reagent stripes
US7727467B2 (en) 2003-06-20 2010-06-01 Roche Diagnostics Operations, Inc. Reagent stripe for test strip
US7892849B2 (en) 2003-06-20 2011-02-22 Roche Diagnostics Operations, Inc. Reagent stripe for test strip
US7867369B2 (en) 2003-06-20 2011-01-11 Roche Diagnostics Operations, Inc. Biosensor with multiple electrical functionalities
US8506775B2 (en) 2003-06-20 2013-08-13 Roche Diagnostics Operations, Inc. Devices and methods relating to electrochemical biosensors
US8679853B2 (en) 2003-06-20 2014-03-25 Roche Diagnostics Operations, Inc. Biosensor with laser-sealed capillary space and method of making
US8945910B2 (en) 2003-09-29 2015-02-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
US9351680B2 (en) 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
US9561000B2 (en) 2003-12-31 2017-02-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US9261476B2 (en) 2004-05-20 2016-02-16 Sanofi Sa Printable hydrogel for biosensors
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9410915B2 (en) 2004-06-18 2016-08-09 Roche Operations Ltd. System and method for quality assurance of a biosensor test strip
US9982289B2 (en) 2004-12-13 2018-05-29 Ascensia Diabetes Care Holdings Ag Size self-limiting compositions and test devices for measuring analytes in biological fluids
EP1885869B1 (en) * 2004-12-13 2012-04-11 Bayer HealthCare, LLC Size self-limiting compositions and test devices for measuring analytes in biological fluids
CN103558369A (en) * 2004-12-13 2014-02-05 拜尔保健有限公司 Size self-limiting compositions and test devices for measuring analytes in biological fluids
US7964372B2 (en) 2004-12-13 2011-06-21 Bayer Healthcare Llc Size self-limiting compositions and test devices for measuring analytes in biological fluids
CN101076601B (en) * 2004-12-13 2013-11-13 拜尔保健有限公司 Size self-limiting compositions and test devices for measuring analytes in biological fluids
US8969097B2 (en) 2005-06-13 2015-03-03 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit-volume correction and feedback control
US9366636B2 (en) 2005-06-13 2016-06-14 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US10226208B2 (en) 2005-06-13 2019-03-12 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US11419532B2 (en) 2005-06-13 2022-08-23 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US10433780B2 (en) 2005-09-30 2019-10-08 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
US9060723B2 (en) 2005-09-30 2015-06-23 Intuity Medical, Inc. Body fluid sampling arrangements
US10441205B2 (en) 2005-09-30 2019-10-15 Intuity Medical, Inc. Multi-site body fluid sampling and analysis cartridge
US9839384B2 (en) 2005-09-30 2017-12-12 Intuity Medical, Inc. Body fluid sampling arrangements
US10842427B2 (en) 2005-09-30 2020-11-24 Intuity Medical, Inc. Body fluid sampling arrangements
US9380974B2 (en) 2005-09-30 2016-07-05 Intuity Medical, Inc. Multi-site body fluid sampling and analysis cartridge
US8940153B2 (en) 2005-11-14 2015-01-27 Bayer Healthcare Llc Test sensor reagent having cellulose polymers
WO2009021907A1 (en) * 2007-08-10 2009-02-19 Unilever Plc Disposable sensor for liquid samples
US9063077B2 (en) 2007-10-31 2015-06-23 Arkray, Inc. Analysis tool and manufacturing method thereof
EP2211172A1 (en) * 2007-10-31 2010-07-28 ARKRAY, Inc. Analyzing tool, and its manufacturing method
EP2211172A4 (en) * 2007-10-31 2014-11-26 Arkray Inc Analyzing tool, and its manufacturing method
US9386944B2 (en) 2008-04-11 2016-07-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte detecting device
US9833183B2 (en) 2008-05-30 2017-12-05 Intuity Medical, Inc. Body fluid sampling device—sampling site interface
US11045125B2 (en) 2008-05-30 2021-06-29 Intuity Medical, Inc. Body fluid sampling device-sampling site interface
US11399744B2 (en) 2008-06-06 2022-08-02 Intuity Medical, Inc. Detection meter and mode of operation
US10383556B2 (en) 2008-06-06 2019-08-20 Intuity Medical, Inc. Medical diagnostic devices and methods
US9636051B2 (en) 2008-06-06 2017-05-02 Intuity Medical, Inc. Detection meter and mode of operation
US11553860B2 (en) 2008-06-06 2023-01-17 Intuity Medical, Inc. Medical diagnostic devices and methods
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US9897610B2 (en) 2009-11-30 2018-02-20 Intuity Medical, Inc. Calibration material delivery devices and methods
US11002743B2 (en) 2009-11-30 2021-05-11 Intuity Medical, Inc. Calibration material delivery devices and methods
US8919605B2 (en) 2009-11-30 2014-12-30 Intuity Medical, Inc. Calibration material delivery devices and methods
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US10330667B2 (en) 2010-06-25 2019-06-25 Intuity Medical, Inc. Analyte monitoring methods and systems
US9782114B2 (en) 2011-08-03 2017-10-10 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US11051734B2 (en) 2011-08-03 2021-07-06 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US11382544B2 (en) 2011-08-03 2022-07-12 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US11672452B2 (en) 2011-08-03 2023-06-13 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US10729386B2 (en) 2013-06-21 2020-08-04 Intuity Medical, Inc. Analyte monitoring system with audible feedback
CN104931549A (en) * 2014-03-19 2015-09-23 深圳市艾瑞生物科技有限公司 Electrochemical test paper for quantitatively measuring homocysteine and preparation method thereof
US11073495B2 (en) 2015-10-15 2021-07-27 Arkray, Inc. Biosensor and manufacturing method of biosensor
EP3156790A1 (en) * 2015-10-15 2017-04-19 ARKRAY, Inc. Biosensor and manufacturing method of biosensor
WO2019016451A1 (en) 2017-07-20 2019-01-24 Lsee Electrochemical strips for monitoring the degradation of body fat and method for preparing same
US11629369B2 (en) 2017-07-20 2023-04-18 Lsee Electrochemical strips for monitoring the degradation of body fat and method for preparing same
US11933789B2 (en) 2021-05-05 2024-03-19 Intuity Medical, Inc. Calibration material delivery devices and methods

Also Published As

Publication number Publication date
AU2847900A (en) 2000-08-01
EP1593958B1 (en) 2010-02-24
BR0008615A (en) 2001-10-16
EP1593959A2 (en) 2005-11-09
BR0008615B1 (en) 2012-09-04
DE60043905D1 (en) 2010-04-08
EP1612548A2 (en) 2006-01-04
JP2002535615A (en) 2002-10-22
CA2358464A1 (en) 2000-07-20
EP1155310B1 (en) 2006-01-04
EP1593958A3 (en) 2006-07-12
DK1155310T3 (en) 2006-03-06
CN1241012C (en) 2006-02-08
EP1155310A4 (en) 2002-11-04
US6241862B1 (en) 2001-06-05
EP1612548A3 (en) 2006-07-12
ES2339122T3 (en) 2010-05-17
ES2255980T3 (en) 2006-07-16
AU763723B2 (en) 2003-07-31
DE60025334T2 (en) 2006-08-10
HK1043832A1 (en) 2002-09-27
HK1043832B (en) 2006-09-29
DE60025334D1 (en) 2006-03-30
JP3699898B2 (en) 2005-09-28
EP1593958A2 (en) 2005-11-09
EP1155310A1 (en) 2001-11-21
CA2358464C (en) 2008-08-26
CN1341210A (en) 2002-03-20
EP1593959A3 (en) 2006-07-05
ATE315223T1 (en) 2006-02-15
ATE458996T1 (en) 2010-03-15

Similar Documents

Publication Publication Date Title
US7807031B2 (en) Disposable test strips with integrated reagent/blood separation layer
US6241862B1 (en) Disposable test strips with integrated reagent/blood separation layer
EP0880692B1 (en) Disposable test strips for determination of blood analytes, and methods for making same
JP4932118B2 (en) Fast response glucose sensor
JP3819936B2 (en) Electrochemical biosensor test strip
CA2375089C (en) Disposable sub-microliter volume sensor and method of making
US6287451B1 (en) Disposable sensor and method of making
CA2470465C (en) Improved biosensor and method
US20020092612A1 (en) Rapid response glucose sensor
US5876952A (en) Non-invasive glucose biosensor: determination of glucose in urine
Chen et al. Disposable glucose test strip for whole blood with integrated sensing/diffusion-limiting layer
AU2006209265A1 (en) Rapid response glucose sensor

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 00804294.2

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 28479/00

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2358464

Country of ref document: CA

Ref document number: 2358464

Country of ref document: CA

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2000 593945

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2000906895

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2000906895

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09869887

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 28479/00

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 2000906895

Country of ref document: EP